Development of high throughput, mammalian cell-based metabolic rate assays for screening compounds by Yang, Yuansheng
DEVELOPMENT OF HIGH THROUGHPUT, MAMMALIAN CELL-BASED METABOLIC 
RATE ASSAYS FOR SCREENING COMPOUNDS 
By 
 
Yuansheng Yang 
 
 
Dissertation 
 
Submitted to the Faculty of the 
 
Graduate School of Vanderbilt University 
 
in partial fulfillment of the requirements 
 
for the degree of 
 
 
DOCTOR OF PHILOSOPHY 
 
in 
 
 
Chemical Engineering 
 
 
May, 2005 
 
 
Nashville, Tennessee 
 
 
Approved: 
 
Professor R. Robert Balcarcel 
 
Professor G. Kane Jennings 
 
Professor Robert D. Tanner 
 
Professor John A. Roth 
 
Professor Owen Patrick McGuinness 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright 2005 by Yuansheng Yang 
 
All Rights Reserved 
 iii
ACKNOWLEDGEMENTS 
 
First and foremost, I thank my advisor, Dr. R. Robert Balcarcel, for his guidance, 
teaching, support, and friendship. I truly appreciate all the time and efforts he devoted to 
my research, personal growth, and career development during my study at Vanderbilt 
University. His work spirit of being a curious and original researcher, critical evaluator to 
research results, and open-minded learner will impact my career for the rest of my life. 
As his first Ph.D. student to graduate, I wish him all the best in his life and future 
research. 
I thank all members in our research group, Sean M. Hartig, Lindsey M. Clark, 
Benjamin Roy, and Tiffany D. Rau, for their help during my research. I especially thank 
Sean for proofreading of my publications, thesis, and improving my English skills, and 
the happiness he added to my life at Vanderbilt University. 
I thank my outstanding doctoral committee members chaired by Dr. Balcarcel  
Dr. G. Kane Jennings, Dr. Robert D. Tanner, Dr. John A. Roth, and Dr. Owen Patrick 
McGuinness. They were kind enough to provide excellent advice and suggestions for my 
research. 
I also want to thank the faculty and staff from the Vanderbilt University Chemical 
Engineering Department. 
In addition, I gratefully acknowledge financial support from the Defense 
Advanced Research Projects Agency (N66001-01-C-8064). 
 iv
I sincerely thank my parents, my brother, and my sister for their unconditional 
love and support from the time when I was born. I could not have been possible to finish 
any work without your support and encouragement.  
Finally, I sincerely appreciate my wife, Xuesong Yang, for all of her support and 
tolerance of my absence over the years. I want you to know that I love you and that I 
could not have done this without your support. 
 v
TABLE OF CONTENTS 
 
Page 
 
ACKNOWLEDGEMENTS iii 
 
LIST OF TABLES  viii 
 
LIST OF FIGURES ix 
 
Chapter 
 
I. INTRODUCTION 1 
 
       Introduction to toxicity testing with mammalian cell cultures 1 
       Introduction to cellular metabolism and metabolic flux analysis 5 
       Motivation and objectives of the dissertation research  8 
       Overview of the thesis  9 
       References  10 
 
II. SPECTROPHOTOMETRIC ACIDIFICATION RATE ASSAY FOR 
PRELIMINARY SCREENING OF METABOLIC ACTIVITY 14 
 
       Abstract 14 
       Introduction 14 
       Materials and methods 17 
             Cell culture and media 17 
             Chemicals 18 
             Monitoring pH during the acidification rate assay 19 
             pH calibration 19 
             Calculation of acidification, glucose, and metabolic rates 21 
       Results 23 
             Monitoring extracellular pH 23 
             Determination and validation of acidification rate 24 
       Discussion 31 
       References 35 
 
 vi
III. DETERMINATION OF CARBON DIOXIDE PRODUCTION RATES FOR 
MAMMALIAN CELLS IN A SEALED 24-WELL PLATE 39 
 
       Abstract 39 
       Introduction 40 
       Materials and methods 41 
             Modeling gas-liquid mass transfer of CO2 produced by cells 41 
             Cell culture and media 45 
             Test chemicals 45 
             Sealing plugs for the 24-well plate CO2 production rate assay 46 
             pH measurement 46 
             Enzymatic assay for total liquid phase CO2 48 
             Determination of CO2 production rates of fibroblast cell cultures treated 
             with chemicals 49 
             Calculation of CO2 production rates 50 
             Additional assays for culture viability 51 
             Growth of fibroblast cell cultures treated with chemicals 51 
             Statistical analysis 52 
       Results 52 
             Simulated dynamic change of CO2 concentration in the liquid and gas 
             phase 52 
             Accumulation of CO2 in plug-sealed wells 54 
             Estimation of headspace CO2 mole fractions 57 
             Monitoring CO2 production rates of fibroblast cell cultures exposed to  
             four chemicals 58 
             Short- and long-term effects of chemicals on growth and death of 
             fibroblast cultures 60 
       Discussion 64 
       References 66 
 
IV. 96-WELL PLATE ASSAY FOR SUBLETHAL METABOLIC ACTIVITY   69 
  
       Abstract 69 
       Introduction 70 
       Materials and methods 71 
             Cell culture and media 71 
             Test compounds 72 
             Enzymatic assays for glucose and lactate 72 
             Resazurin reduction assay for relative culture viability 74 
             Protocol for 96-well plate assay for sublethal metabolic activity 75 
             Calculation of lactate production, glucose uptake, and resazurin 
             reduction relative to control cultures 76 
             Determination of IC50 for metabolism, IC50 for resazurin reduction 
             and the sublethal metabolic activity range 77 
             Statistical tests 78 
       Results 79 
 vii
             Determination of sublethal metabolic activity for fibroblast cultures 
             treated with glycolysis inhibitors 79 
             Comparison of sublethal metabolic activity during 6-h and 24-h 
             exposures 83 
             Comparison of sublethal metabolic activity based on glucose 
             consumption versus lactate production 86 
       Discussion 87 
       References 89 
 
V. METHOD FOR CHARACTERIZING CHANGES IN METABOLIC STATE 
OF MAMMALIAN CELLS 92 
 
 Abstract 92 
       Introduction 92 
       Materials and methods 94 
             Cell culture and media 94 
             Test chemicals 96 
             Metabolic rate screening 96 
             Metabolite assays 98 
             Calculation of concentration differences 99 
             Metabolic network model and consistency with sets of  
             measured rates 100 
             Statistical tests 105 
       Results 106 
             Determination of concentration changes of glucose, lactate, and CO2 106 
             Comparison of sensitivities of responses of the three metabolic rates 
             to each chemical 108 
             Metabolic shift indicated by changes in ratios of metabolic rates 111 
             Changes in consistency between the carbon balance and the measured 
             metabolic rates 114 
       Discussion 119 
       References 122 
  
VI. CONCLUSIONS AND RECOMMENDATIONS 127 
 
       Conclusions 127 
       Recommendations 128 
       References 132 
 
 
 
 
 
 
 viii
LIST OF TABLES 
 
Table                                                                                                                               Page 
3.1. Comparison of measured and calculated total liquid phase CO2 57 
4.1. IC50 values for lactate production and resazurin reduction and 
sublethal metabolic activity range for five compounds tested on 
fibroblast cultures during 6-h exposures 83 
5.1. Sublethal concentration range for each compound 97 
5.2. Reactions used for the metabolic networks 101 
5.3. Change in metabolite concentration, ratio, and residual 107 
6.1. Summary of metabolic rate assays developed in this work 128 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix
LIST OF FIGURES 
 
Figure                                                                                                             Page 
1.1. Schematic overview of the connection between compositional and 
functional units in metabolic systems 6 
2.1. Measured absorbance of phenol red at 562 nm at different pH values 
in the 24-well plate filled with 600 µL of test medium without cells 21 
2.2. Monitoring pH of fibroblast cultures exposed to five chemicals 27 
2.3. Relative acidification (black bars), lactate production (gray bars), 
and glucose uptake (clear bars) rates for fibroblast cultures exposed 
to different concentrations of (A) DNP, (B) AA, (C) fluoride, (D) 
Rotenone, and (E) Oxamate 30 
2.4. Correlation of medium acidification rate with lactate production rate 
of fibroblast cells exposed to DNP, AA, rotenone, or fluoride 31 
2.5. Interaction sites for DNP, AA, fluoride, rotenone, and oxamate on 
metabolic pathways 33 
3.1. Sealed well-plate system for CO2 production rate assay.  (A) Side 
view section of well sealed with a plug 47 
3.2. Simulated distribution of CO2 produced by cells in liquid phase and 
gas phase in open and sealed conditions 53 
3.3. Measurement of total liquid phase CO2 in open and sealed-well 
fibroblast cell cultures 54 
3.4. Comparison of well plate fibroblast cell culture glucose uptake and 
lactate production in open and sealed condition 56 
3.5. Determination of CO2 production rates for fibroblast cell cultures 
exposed to four toxic chemicals 60 
3.6. Culture viability immediately following a 6-hr exposure 62 
3.7. Effect of chemicals on cell growth 64 
4.1. Resazurin reduction and lactate production for fibroblast cell 
cultures exposed for 6 h to different concentrations of phloretin (A), 
2-DG (B), iodoacetate (C), fluoride (D), and oxamate (E) 82 
 x
4.2. Comparison of IC50’s and sublethal ranges determined during 6-h 
versus 24-h exposures 86 
4.3. Comparison of 24-hr IC50 values based on lactate production and 
glucose consumption 87 
5.1. Metabolic networks 101 
5.2. Changes in concentration differences of glucose, lactate, and CO2 of 
fibroblast cell cultures exposed for 6 h to different concentrations of 
oxamate (A), fluoride (B), antimycin A (C), and DNP (D) 110 
5.3. Comparison of responses of metabolic rates of glucose, lactate, and 
CO2 to each chemical 111 
5.4. Changes in ratios of concentration differences of metabolites of 
fibroblast cell cultures exposed to four chemicals 113 
5.5. Frequency distributions of normε  calculated from 30 control cultures  115 
5.6. Normalized residuals for fibroblast cells exposed to four chemicals 117 
5.7. Changes in metabolic state of fibroblast cells exposed to four 
chemicals 119 
 1
CHAPTER I 
 
INTRODUCTION 
 
Introduction to toxicity testing with mammalian cell cultures 
Chemical toxicity has been a public concern due to adverse effects on human 
health and environment. All chemicals, no matter for pharmaceutical or industrial 
purposes, need to go through extensive toxicity testing before they are released for public 
use as required by regulatory agencies.1 In many cases, development and application of a 
product has to be discontinued due to its toxic effects, which makes this knowledge of 
significant economic value.2,3 Toxicity testing usually involves a large number of animal 
experiments.2,4 However, there is much pressure to reduce the use of animals due to 
practical, economic, and ethical reasons.5,6 This is especially true for processes which 
involve large numbers of compounds, particularly in drug discovery and development; 
millions of compounds are screened at the beginning and early toxicity information is 
required for confirmation of the most appropriate candidates for further development.7-9 
In short, there is a increasing need for development of cost effective, high throughput in 
vitro methods as animal substitutes.6 
Cultured cells, which keep the complexity of life in a very simplified system, 
provide an attractive alternative to whole animals for toxicity testing. The use of cell 
culture for measuring chemical toxicity has attracted much attention since the 1970s.10 
The many efforts devoted to this field over the past years are demonstrated by new 
research centers and organizations as well as publications.11-13 Many cell-based toxicity 
 2
testing methods have been developed and their applications are becoming increasingly 
acceptable due to their practical and economical convenience while providing 
information relevant to in vivo.14,15 
In contrast to animal testing, toxicity tests using cultured cells for many variables 
and replicates are cheaper, and the ethical, economical, and technical questions of animal 
experimentation are avoided.16 Scientifically, the simplified, well controlled experimental 
system reduces the variability and bioavailability problems of animal experiments. 
Moreover, the better controlled experimental conditions offer the ability to obtain more 
refined mechanistic information on toxicity at the cellular level, which may be lost or 
masked in the intact organisms.12 Furthermore, the availability of cell lines from different 
origins allows “elementary analysis” of a complicated toxicity event. Integration of the 
cellular events, organ specific events, and kinetic events may generate a sensible toxicity 
profile more efficiently than using animal-based approaches.2,4,12,14,17 
However, there are many limitations for toxicity testing with cell cultures. Certain 
effects occurring in vitro for a certain cell type may not represent the toxic effects caused 
by the chemical in the intact organism. First, the processes regarding absorption, 
distribution, metabolism and excretion (ADME) are omitted, which not only affect the 
final concentrations reaching the target in vivo, but also sometimes change the chemical 
behavior.2,4,14,17 Second, many cultured cell behaviors and their counterparts in vivo are 
different. The specific cell interaction characteristics of the tissue histology are lost, and 
as the cells are propagated in the synthetic medium, many differentiated functions may be 
lost or changed.16 Third, in some cases, toxic effects in vivo are due to a tissue response 
(e.g. an inflammatory reaction, fibrosis) or a systemic response (e.g. pyrexia, vascular 
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dilation), which can not be monitored at the cellular level.1,17 Considering these 
limitations, it is recognized that application of cell culture for obtaining mechanism-
derived information is more promising than toxicity quantification.14  
Current methods of toxicity testing with cell cultures are mainly used in the early 
stage of any toxicological approach with the exception of very specialized tests. Three 
types of testing can be identified.3,12,14,18,19 The most common type of testing is screening 
as preliminary steps in a complex strategy, mainly for priority setting and determination 
of active concentration ranges to narrow the scope for subsequent investigations. 
Secondly, there are many tests used for determining the mechanism of action of 
chemicals to complement to the animal tests. Thirdly, a few tests are also used as animal 
alternatives for make a definitive toxicological assessment. 
Up to now, most in vitro methods have been focused on acute toxic effects (<24 
hr). This is mainly due to the challenge of maintaining cell-specific functions in long-
term cell culture.14 As a result of the multitude of biological structures and processes that 
can be impaired by different types of chemicals, there are a tremendous number of toxic 
effects and many different ways to test toxicity at the cellular level, or cytotoxicity. 
Biochemical, physiological, and molecular events all can provide measures of toxicity or 
valuable mechanistic information. Many endpoint assays have been developed based on 
membrane damage, mitochondrial dysfunction, changes in metabolism, morphology, and 
cell replication.11,14 They are widely used because they are cheap, easily quantified, and 
reproducible. However, all of these assays oversimplify the events that they measure, 
providing a binary outcome for multiple step, kinetic processes. The obtained information 
is limited and not mechanistically indicative. There is a growing need to supplement them 
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with more subtle yet revealing tests for molecular events and precise metabolic 
regulation.1 
Many technologies have been developed for analysis of cellular components, such 
as genomics (DNA micro-assay) and proteomics (2D-Gel-Mass Spectrometry), which 
now enable simultaneous measurements of thousands of gene expression and protein 
levels. Their uses for toxicity testing provide the opportunity to define the molecular 
events that precede and accompany toxicity at unprecedented levels of detail. 
Expectations are high for their potential in toxicology, which has stimulated the 
emergence of a new research area, toxicogenomics.20 Their applications have been 
identified in at least two areas of toxicity testing: mechanistic investigations and 
predictive toxicology.20-25 For mechanism studies, valuable clues could be provided by 
examining changes in gene expression for further investigation of targeted molecules. In 
contrast, the basis of the second approach is more empirical. In this approach, databases 
containing expression patterns are constructed from compounds with known toxicity, 
with which to predict toxicity of unknown chemicals. Some preliminary studies have 
applied genomics and proteomics in studies of mechanisms and discrimination of classes 
of toxicants.26,27 
However, many challenges remain to realize their potential in toxicology14,25. 
First, the technologies are still not mature and further improvements with respect to 
speed, cost, and sensitivity are needed for screening purposes. Second, both techniques 
are very labor intensive and expensive, rendering them accessible only to few research 
groups. Third, cellular components themselves do not allow functions to be inferred 
without considering dynamic metabolic status. Moreover, in some cases, xenobiotics may 
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not affect gene regulation and expression directly, and significant toxicological effects 
may be completely unrelated to gene switching. Thus, metabolic status should be 
included to augment and complement the information collected by genomics and 
proteomics.14,23,25 
 
Introduction to cellular metabolism and of metabolic flux analysis 
Metabolism is the overall process through which living systems acquire and use 
free energy to carry out their functions.28 Cellular metabolism is generally expressed as 
sequenced biochemical reactions in the form of a metabolic network. The pioneering 
research has constructed a complex metabolic network map. Generally, only inclusion of 
feasible and observable biochemical reaction steps in a network is valuable for specific 
metabolic studies. In many ways, it is preferable to simplify the network by lumping a 
series of linear reactions as one pathway whose overall flux can be experimentally 
determined.29,30 Inside the network, any sequence of biochemical reaction steps 
connecting a specified set of input and output metabolites is called a metabolic pathway, 
and the rate at which material is processed through a metabolic pathway is defined as the 
metabolic flux. 
The metabolic fluxes define the minimum information needed to describe cellular 
metabolism.29 In a cellular system, the metabolic behavior, as indicated by the fluxes, is 
the culmination of regulatory processes at multiple levels, including metabolite substrates 
and intermediates, expression of enzymes and regulatory proteins, and the transcription 
of genes into mRNA based on the sequence information of DNA components (Figure 
1).31 Residing at the median of a biological paradigm, metabolic fluxes provide a link 
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between genetics and cell physiology. Quantitative determination of metabolic fluxes and 
flux analysis can help connect effects of genetic and/or environmental modifications to 
cell physiology.32  
 
Genome Transcriptome Proteome Metabolome
Interactions within and between “omes”
Fluxome
Fluxes through network
Cell Physiology 1-100
(Cell death, cell growth, …)
 
 
Figure 1.1. Schematic overview of the connection between compositional and functional 
units in metabolic systems. 
 
 
 
The metabolic fluxes generally can be estimated using metabolite balancing and 
isotopic tracer methods. The former approach applies mass balances around the network 
of intracellular metabolites to calculate metabolic fluxes throughout the network under 
the assumption of steady state or quasi-steady-state.30,33 Inputs for this analysis are the 
uptake and secretion rates of extracellular metabolites. The latter approach is based on the 
notion that activities of metabolic pathways can be determined by providing substrates 
enriched in carbon isotopes (typically 13C or 14C) and analyzing the distribution of the 
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isotopes in metabolic intermediate.34-37 Isotopic tracers incorporated into metabolites can 
be detected using nuclear magnetic resonance (NMR) spectroscopy or mass 
spectroscopy. Although the isotopic methods are powerful to quantify more detailed 
metabolic pathways even for complex metabolic networks, the high cost of equipment, 
the cumbersome operation, and the difficulty of data interpretation limit their 
applications. In general, metabolite balancing is the easiest method for obtaining fluxes 
for a given metabolic network.33 With a list of flux estimates for a metabolic network 
under various conditions, changes in fluxes and flux distribution around branch points 
can provide insights into how cells regulate metabolism under various conditions. 
Traditional methods have often measured metabolic rates of biological systems in 
large volumes of cultivation systems (such as flasks and reactors) operated in continuous, 
batch, or fed-batch mode.32 They have often been used for conducting metabolic studies 
in bioprocess and bioengineering research to improved cellular properties.29,37,38 
Measuring metabolic rates in large-scale systems is preferable because the obtained 
information is more relevant to industry. However, these approaches are time consuming, 
expensive, labor- and instrument intensive and not suitable for screening purposes.32 
Continuous bioreactor cultures allow for precise determination of metabolic rates under 
well-defined environmental conditions.30 However, running a continuous bioreactor 
system to obtain data for just one steady state following inoculation of the bioreactor 
takes about 10-30 days, depending on the dilution rate. Operating a small, readily, 
commercially available bioreactor (working volume at 1.0 liter) in continuous mode at a 
dilution rate of 1.0 L/day costs approximately $ 40/day just for the raw materials and 
without accounting the cost from the large amount of testing agents. Moreover, the time 
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and high cost required per experiment results in fewer replicates to check reproducibility. 
Even using relatively time efficient and cost effective batch experiments, data acquisition 
for one experimental point can take days. 
 
Motivation and objectives of the dissertation research 
Functional characterization of diseased metabolic states is necessary for a holistic 
toxicity profile. At the start of this thesis, established approaches for conducting studies 
of metabolism were not suitable for screening toxicants and drugs due to obstacles such 
as high cost, labor, lengthy time consumption, low reproducibility and throughput. Easily 
performed, inexpensive, and high throughput methods for measuring cellular metabolic 
rates of mammalian cells were identified as a urgent needed to meet this deficit. 
Development of such methods for metabolic studies is also required in other areas, such 
as screening mutant collections in functional genomics, identification of pathways for 
genetic modification in metabolic engineering, and screening cell lines and media for 
preliminary optimization to ensure better cellular properties in bioprocess 
development.31,39 
The overall aim of my research was to develop and apply high throughput 
metabolic rate assays for characterizing effects of compounds on cellular metabolism. To 
combat the high cost and low throughput of conventional methods for measuring 
metabolic rates in large scaled bioreactors or flasks, the assays that I developed would be 
performed in 24- or 96-well plates, which allow for multi-parallel, 100-500 µL cell 
cultures to simultaneously test many chemicals with adequate replication. Average 
metabolic rates would be measured in batch mode for a short period during which 
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changes in metabolite concentrations are sufficient to detect a difference, but not so much 
as to affect cell physiology and metabolic states. To handle the large amount of samples 
produced from the well plate systems, certain metabolites would be measured using dye-
based or enzymatic methods, which allow multiplexed detection using high throughput 
fluorescence or spectrophotometric microplate readers. 
  
Overview of the thesis 
By recognizing that one assay cannot satisfy all purposes, a series of assays were 
developed which can be used alone or in a sequence depending on the information 
needed. In chapter II, a 90-min, 24-well plate acidification rate assay based on 
spectrophotometric detection of phenol red was developed for screening global metabolic 
effects of chemicals. The assay is simple, inexpensive and suitable for rapid measurement 
of short time, global metabolic effects. In chapter III, a 24-well plate CO2 production rate 
assay was developed for the determination of CO2 production rate of mammalian cells. 
The viability and cell growth were measured as comparison to validate its application for 
toxicity testing. It is found that metabolic change corresponds to growth inhibition and 
there is a sublethal concentration range for a chemical where changes in metabolism 
occur but without causing cell death. Inspired by the finding that metabolic change occurs 
at sublethal concentrations, and motivated that dose selection remains a challenge in 
toxicity testing, in chapter IV, a 96-well plate assay which combines resazurin reduction 
with lactate production and glucose consumption rate assays was designed to assess 
effects of compounds on both culture viability and metabolism during 6 or 24 hr 
exposure. The assay was used to bound sublethal, metabolic active concentration ranges 
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for a chemical to serve as a cost-effective and time-saving step for subsequent 
investigations with more expensive, lengthy, and/or detailed methods. The previous three 
assays paved the way for a more detailed investigation of effects of compound on cellular 
metabolism. In chapter V, based on the three developed assays, a 24-well plate assay was 
synthesized for simultaneous measurements of glucose, lactate and CO2/pH. The assay, in 
conjunction with a carbon material balance model and statistical analysis, was used to 
characterize the changes in metabolic state of mammalian cells exposed to four model 
metabolic agents. In contrast to traditional methods which mainly focused on the late, 
irreversible cell death events, the metabolic responses at sublethal levels were 
investigated. In the last chapter, VI, the major conclusions of this study are summarized 
and potential applications of the developed assays are discussed. 
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CHAPTER II 
 
SPECTROPHOTOMETRIC ACIDIFICATION RATE ASSAY FOR 
PRELIMINARY SCREENING OF METABOLIC ACTIVITY 
 
 
 
Abstract 
A 90-minute assay using 24-well plates was developed for screening global 
metabolic effects of chemicals by measuring extracellular acidification rate of 
mammalian cells. During a 90-minute test, the pH of each well of a 24-well plate is 
monitored by measuring the absorbance of phenol red using a spectrophotometric plate 
reader. The acidification rate is then calculated from the change in pH divided by the time 
interval and cell density. The assay was verified by testing the effects of five well-
characterized chemicals on fibroblast cell cultures. As expected, the responses of the 
fibroblasts were dependent on the dose and type of chemicals. They also corresponded 
with their established mechanisms of action and well with measured lactate production 
rates. The set up is simple, inexpensive and amenable to be automated. The method is 
easy to perform and rapid. Uses include screening compounds for gross metabolic effects 
in mammalian cell lines, determining preliminary metabolic dose-response curves for 
guiding further research, and designing and optimizing media for in vitro systems 
utilizing cell cultures. 
 
Introduction 
Recent advances in organic chemistry (combinatorial chemistry) have led to the 
development of large chemical libraries, which not only drive the rapid development of 
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pharmaceutical and other industries, but also further increase the burden of toxicity 
testing which mainly rely on animal experiments.1,2 There is an increasing need for rapid, 
high throughput, and cost-effective in vitro toxicity testing methods as animal 
alternatives.3 In recent years, mammalian cell-based, high-throughput toxicity screening 
has played an important role in drug development and toxicological safety testing, 
especially at early stages.4-6 In general, the purpose of one toxicity screen would not 
necessarily be to predict the extent and nature of all possible effects, but rather to provide 
information for narrowing the scope of subsequent investigations that could be more 
information containing but also expensive and time-consuming, thereby enhancing the 
overall efficiency and decreasing the overall cost for a entire toxicological testing 
process.1,3,7  
Quite a few high-throughput assays have been developed for in vitro drug and 
toxicity screening. Many of them are biochemical assays for specific enzyme activities 
related to basic cellular functions, which can be measured based on change in light 
absorption, fluorescence or luminescence intensity. The assays are amenable for 
miniaturization and automation. The commonly used commercial assays include ATP-
based luminescence assay,8-10 Alamar blue assay,7,11,12 LDH leakage,13,14 and MTT.15-17 
However, these assays require the addition of assay reagents at the end of exposure and 
additional incubation times in order to generate a signal. These extra steps may distort the 
effects of the chemicals and provide obstacles for adaptation for high- or ultrahigh-
throughput screening automation.9,18  
Screening cell lines for effects of chemicals on metabolism can provide another 
alternate, non-specific test, as all compounds can cause global changes in cell 
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metabolism. The changes in consumed nutrients or excreted metabolites all can be used 
as indicators for changes in metabolism. In this vein, measuring uridine uptake has been 
reported for toxicity testing.19 However, this assay is relatively expensive and labor 
intensive, and requires the handling and disposal of radioisotopic waste. The well plate-
based BD oxygen biosensor system developed by BD Science Company has been 
reported for monitoring oxygen consumption rate. However, the assay is limited to the 
use of suspended cell line and its low sensitivity requires the use of high density of 
cells.18 Measuring medium acidification rate provides another alternative for monitoring 
changes in metabolism. The rationale of using acidification rate as a general index of 
metabolism is based on the fact that the extracellular pH is a strong function of lactate 
and CO2 production from the cells.20,21 In contrast to measurement of other metabolites, 
the advantage of using pH is that it is sensitive to both glycolytic metabolism and 
respiration.22 Moreover, measuring acidification rate has also been found to be more 
sensitive than other cytotoxicity assay methods such as MTT.23 Monitoring medium 
acidification rate has been reported using a 4- or 8-channel Molecular Devices 
Cytosensor. Its applications have been identified in different steps of drug development 
as a functional assay or generally as a cytotoxicity assay.20,21,24-26 However, this method 
is not well suited for multiple parallel measurements and is not applicable for high 
throughput screening.26  
In this work, I present a 24-well plate assay for mammalian cell culture 
acidification rate that characterizes the metabolic effects of chemicals such as 2,4-
dinitrophenol (DNP), antimycin A (AA), rotenone, sodium fluoride, and sodium 
oxamate.  Our results demonstrate the feasibility of performing the acidification rate 
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assay in a multi-replicate format and of screening chemicals for their impact on overall 
metabolic activity.  The assay is relatively simple, fast (90 minutes), fairly inexpensive, 
multi-replicate, and is also amenable to automation.  It can be used in screening 
sensitivity of cell lines to classes of agents, to better define the concentration ranges 
where agents cause measurable metabolic effects on cell lines, as well as in formulating 
and optimizing media for cell culture studies. 
 
Materials and methods 
Cell culture and media 
Mouse fibroblast cells (ATCC CRL10225) used in this study were grown in 
“maintenance medium” consisting of DMEM (Mediatech, Herndon, VA, USA) 
supplemented with 10% FBS (Sigma, St. Louis, MO, USA), 10 U/mL penicillin-10 
µg/mL streptomycin (Sigma), and 4 mM L-glutamine (Mediatech). The cells were 
maintained in 75 cm2 T-flasks (Corning, NY, USA) in an incubator (Model 3100 series, 
Forma Scientific, Marietta, OH, USA) controlled at 37 °C, 95% humidity, and 10% CO2. 
Every 4-6 days, cultures were trypsinized using a 0.25% solution of trypsin (Mediatech), 
counted by microscopy (Model BX60, Olympus, USA) using trypan blue (Mediatech) 
with a hemacytometer (Double Neubauer Counting Chamber Set, VWR International, 
Suwanee, GA, USA), and subcultured at an initial cell density of 2×105 cells/mL in 
maintenance medium. 
Medium for the 90-min 24-well plate acidification assay (test medium) is based 
on a low-buffered bicarbonate-free RPMI 1640 medium containing 1 mM phosphate 
(Molecular Devices), which is supplemented with 10 mg/L insulin, 5 mg/L holo-
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transferrin, and 10 U/mL penicillin–10 µg/mL streptomycin (Sigma Chemical Co.). 
Sodium bicarbonate is not added since loss of CO2 converted from it negatively interferes 
with the monitoring of pH. Moreover, the test medium is modified to contain 25 mg/L 
phenol red for clearer signals of phenol red absorbance. Furthermore, the initial pH is 
adjusted to a value of 7.7 to make the pH of the medium more sensitive to acidification 
since this higher pH is further from the buffer pKa of phosphate at 7.21.27  
Medium for 6-hr 24-well plate glucose and lactate rate assays consisted of RPMI 
1640 (Sigma Chemical Co.) supplemented with 2g/L sodium bicarbonate, 4.0 mM D-
glucose, 10 mg/L insulin, 5 mg/L holo-transferrin, and 10U/ml penicillin-10 µg/mL 
streptomycin, as reported but without 2-aminoethanol and 2-mercaptoethanol. 28 
Chemicals 
DNP, antimycin A, rotenone, sodium fluoride, and sodium oxamate were 
purchased from Sigma Chemical Co. Concentrated stock solutions of DNP, antimycin A, 
and rotenone were made in ethanol, while concentrated sodium fluoride and sodium 
oxamate were made in sterilized water. Prior to a screen, 5.0-mL volumes of test media 
with 4 concentrations of a chemical plus a control without containing chemicals were 
prepared by further dilution of a concentrated stock into test medium. The pH was 
adjusted to the equal value of 7.7 with hydrochloride and/or sodium hydroxide. Test 
media of different concentrations of a chemical were still administered the same total 
amount of solvent. The maximum concentration of solvent used (from the stock solution) 
was less than 2% vol/vol. 
 19
Monitoring pH during the acidification rate assay 
In preparation of a screen, the fibroblast cells are harvested from a 75-cm2 T-flask 
at 80-90% fluency, centrifuged at 200 g for 10 min (model 5677, Forma Scientific), and 
resuspended in maintenance medium at a density of 1.5x106 cells/mL. High cell density 
is used for clearer signal of acidification rate.  600 µL of this cell culture is placed into 
each well of a 24-well plate (BD Falcon), with the exception of 4 wells that are reserved 
for cell-free medium. The plate is incubated at 37°C, 95% humidity, and 10% CO2 for 10 
hours to allow cell attachment. Next, maintenance medium is removed, all wells are 
washed twice with PBS, and 600 µL of test media with 4 different concentrations of an 
agent plus control is added to each well of a 24-well plate, each column corresponding to 
one concentration. The cell-free wells were also added with test medium without 
containing chemicals.  The plate is thereafter placed on the FL600 (Bio-Tek Instruments, 
Winooski, VT) for monitoring and temperature control at 37°C during the 90-min 
acidification rate assay. The absorbance at 560 nm of each well is measured to estimate 
pH every 15 min for 90 minutes. Twenty-five locations were scanned to obtain the 
average for each well. At the end of the monitoring period, culture viability is determined 
in one well of each column (of each concentration) by trypan blue exclusion method 
(Double Neubauer Counting Chamber Set, VWR International, Suwanee, GA). 
pH calibration 
Phenol red (phenolsulphonephthalein, C19H15O5S) is a weak acid, which is 
generally contained in medium as a pH indicator in cell culture. It is the color change 
during its dissociation that is used for pH estimation (Equation 2-1).  
−+ +→← IndHHInd        (2-1) 
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It is red at pH 7.4 and becomes orange at 7.0, yellow at pH 6.5, lemon yellow 
below pH 6.5, more pink at pH 7.6, and purple at pH 7.8. 
The qualitative assessment of color is highly subjective, but quantitative pH 
monitoring can be achieved by measuring absorbance at 560 nm. To set up a calibration 
line for pH monitoring, twelve standard solutions are prepared which vary pH from 3.54 
to 10.01. The standard solutions are test media whose pH’s are adjusted using acid 
chloride or sodium hydroxide. 600 µL of these standard solutions are added to each well 
of a 24-well plate, each column corresponding to one pH value. The well plate is then 
placed on the FL600 plate reader which temperature is maintained constant at 37°C. After 
incubation inside the plate reader for 15 minutes until the temperature of the standard 
solutions reaches 37°C, the absorbance at 560 nm of each well is measured. The 
calibration curve as depicted in figure 2.1 shows the relation between pH values and the 
absorbance values, which can be described by a linear equation based on the Henderson-
Hasselbalch equation as done previously:29,30 

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Amin and Amax were determined from absorbance reading at low and high pH (3.54 
and 10.01) to be 0.2335 and 1.0142, respectively. Six absorbance measurements made for 
medium at pH values between 6 and 8 were used to fit the equation parameters B1 and 
B2 by linear regression in Microsoft Excel. Values that we determined for B1 and B2, 
namely 7.70 and 1.04, agree well with the Henderson-Hasselbalch equation that states B1 
is equivalent to the pKa of the indicator, which is 7.9 for phenol red,27 and B2 is close to 
unity. 
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Figure 2.1.  Measured absorbance of phenol red at 562 nm at different pH values in the 
24-well plate filled with 600 µL of test medium without cells. At every point, mean 
values and standard deviations for four measurements are shown. 
 
 
 
Calculation of acidification, glucose, and lactate metabolic rates 
The pH of each well is determined from absorbance readings using the calibration 
line that is established for test medium. Additionally, for wells that contain cells, the 
absorbance readings are adjusted by subtracting the absorbance due to the presence of 
cells. This absorbance due to cells is determined for each well at time zero as the 
difference between the OD of wells with cells and the OD of wells without cells at time 
zero, when the pH of all the wells are the same. 
The acidification rate for each well of this pH monitoring experiment is calculated 
as the total change in proton concentration at 90 minutes minus the change associated 
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with the wells without cells, divided by the cell density of the seed culture and time 
interval of 90 minutes. Average rates for control and test cultures were taken as the 
average and standard deviation from 4 wells. 
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       (2-3) 
Glucose consumption and lactate production rates were determined during 
separate experiments using another 24-well plate method. After cell attachment, 
maintenance medium is removed, and 400 µL of test medium for the glucose and lactate 
rates assays is added to each well. Next, the well plate is incubated for six hours at 37 °C, 
95% humidity, and 10% CO2. Finally, culture viability is determined in one well of each 
column by removing and counting the cells stained with trypan blue on a hemocytometer. 
Samples for initial and final concentrations of glucose and lactate are removed before and 
after six hours incubation period. Triplicate measurements of glucose and lactate 
concentrations for each well of a 24-well plate at initial and final time points are 
conducted in a separate 96-well plate using enzymatic assays.28 More details about the 
recipes and procedures of both assays are described in Chapter IV. 
Calculation of glucose and lactate rates is similar as for acidification rate. Rates 
for each well of the experiment were calculated as the change in concentration divided by 
the cell density of the seed culture and the time interval of 6 hours (Equation 2-4). 
Average rates for control and test cultures were taken as the average and standard 
deviation from 4 wells. 
tn
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Statistical significance of differences in measured rates between test and control cultures 
were compared using a Dunnett’s test in software JMPIN™. 
 
Results 
Monitoring extracellular pH 
Monitoring of pH in 24-well plates was demonstrated for the exposure of 
fibroblasts to five chemicals: DNP, antimycin A, sodium fluoride, rotenone, and oxamate. 
Figure 2.2 shows the dynamic pH profiles during 90 minutes for cell-free wells, control 
cultures, and test cultures containing chemicals given four different concentrations. The 
concentrations used were based loosely about those reported for other cell lines in recent 
literature 31-33, and in some cases with some foreknowledge from glucose and lactate rate 
assays.28 The pH for cell-free wells dropped by approximately 0.3 pH unit in the first 30-
45 minutes of the assay, but then remained fairly stable. This change in cell-free cultures 
is due primarily to a change in plate temperature from about ambient (25-30°C) during 
preparation of the plate up to the set point temperature of the plate reader (37°C). Even 
though the cell free cultures exhibit changes in pH, the data demonstrate that the cell-
containing cultures exhibit notably greater changes that can be clearly distinguished from 
the cell-free curve. Among the wells containing cells, the changes in pH are also quite 
clearly distinguished between many of the concentrations tested. Whether a test well (one 
with a certain concentration of a chemical) changes to a similar, greater, or lesser degree 
as compared to control wells (wells with cells but no chemical) depends on the chemical 
and the dose. Among the chemicals shown, pH changes in the presence of fluoride and 
oxamate were smaller than that of the control, in a monotonic fashion over the 
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concentration ranges tested.  The opposite was true for cultures given rotenone: the pH 
changes were larger with increasing dose. Non-monotonic trends were evident for other 
chemicals. Cultures with DNP exhibited increased changes in pH for all four 
concentrations tested; yet the maximum increase occurred for intermediate doses of 0.10-
0.20 mM. Cultures with Antimycin A had changes in pH that were greater than those of 
the control for lower doses tested (0.005-0.010 mM), yet smaller than the control at 
higher doses (0.04-0.1 mM). These changes in pH occurred in the absence of significant 
changes in cell number and without observable cell death, as was confirmed by trypan 
blue cell counts immediately following the 90-minute test interval. 
Determination and validation of acidification rate 
Calculated acidification rates more clearly demonstrate the impact of each of the 
four chemicals on overall metabolism (Figure 2.3). Cultures with DNP and rotenone 
exhibited increased acidification rates while cultures with fluoride and oxamate exhibited 
decreased acidification. Cultures with AA had increased acidification rates at lower 
concentrations while decreased rates at higher doses. These calculated acidification rates 
correspond well with lactate production and glucose uptake rates (also shown in Figure 
2.3) that were obtained in 6-hour experiments that were conducted separately from the 
acidification assay. As would be expected, a high level of correlation was found between 
acidification rates and lactate production rates (Figure 2.4).  Culture viability and cell 
number was also assessed at the end of the 6-hour experiments. With the exception of 
cultures exposed to 0.04 and 0.10 mM antimycin A, all cultures retained high viability 
and cell numbers that were unchanged during the 6-hour incubation period. Even though 
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they did not exhibit such traits at 90 minutes, the two cultures given higher doses of AA 
had very low viabilities and significant cell detachment at the end of 6 hours. 
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Fig 2.2. Monitoring pH of fibroblast cultures exposed to five chemicals. (A) DNP: test 
medium without cells (g), test medium with cells ("control") (♦), and test media 
containing DNP at 0.05 (S), 0.10 ( ), 0.20 (∆), and 0.40 (×) mM;  (B) AA: test medium 
without cells (g), test medium with cells ("control") (♦), and test media containing AA 
at 0.005 (S), 0.010 ( ), 0.040 (∆) and 0.100 (×) mM;  (C) Fluoride: test medium without 
cells (g), test medium with cells ("control") (♦), and test media with fluoride at 0.5 (S), 
1.0 ( ), 2.0 (∆), and 4.0 (×) mM;  (D) Rotenone: test medium without cells (g), test 
medium with cells ("control") (♦), and test media containing rotenone at 0.015 (S), 
0.030 ( ), 0.060 (∆) and 0.090 (×) mM; and (E) Oxamate: test medium without cells (g), 
test medium with cells ("control") (♦), and test media with oxamate at 1.0 (S), 2.0 ( ), 
4.0 (∆), and 8.0 (×) mM. pH values reported are the mean and standard deviation of 
measurements from four separate wells. Viabilities of all cultures were greater than or 
equal to 90% at the end of the 90-minute interval. 
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Fig 2.3. Relative acidification (black bars), lactate production (gray bars), and glucose 
uptake (clear bars) rates for fibroblast cultures exposed to different concentrations of (A) 
DNP, (B) AA, (C) fluoride, (D) Rotenone, and (E) Oxamate.  Acidification rates were 
measured over 90 minutes. Lactate production and glucose uptake rates were measured 
over 6 hours. Viabilities of all cultures were greater than or equal to 90% at the end of the 
90-minute interval and 6-hour interval, with the exception of cultures exposed to 0.04 and 
0.10 mM of AA for 6 hours.  Each bar is the average of four wells, and error bars reflect 
the standard deviation of the normalized values. Asterisks denote that differences in test 
cultures compared to controls are statistically significant with p<0.05.  
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Fig 2.4. Correlation of medium acidification rate with lactate production rate of fibroblast 
cells exposed to DNP, AA, rotenone, or fluoride.  Data from cultures exhibiting high 
viability during both assays: DNP at 0, 0.05, 0.10, 0.20, and 0.40 mM; AA at 0, 0.005, 
and 0.010 mM; fluoride at 0.0, 0.5, 1.0, 2.0, and 4.0 mM; and rotenone at 0, 0.015, 0.030, 
0.060, and 0.090 mM; and oxamate at 0, 1.0, 2.0, 4.0 and 8.0 mM. The correlation 
coefficient is 0.88 for 23 points (5 points coincide at 100%-100%). 
 
 
 
Discussion 
The creation of this 24-well plate assay for acidification rate of mammalian cells 
was accomplished through several key modifications. First, the interference of 
temperature on pH measurement was minimized by using a plate reader which can 
maintain a constant temperature during monitoring. Moreover, the effect of change in 
temperature at the start of a pH monitoring experiment was accounted for by including 
the monitoring of wells that only contain medium. Second, a higher phenol red 
concentration and bicarbonate-free media resulted in clearer signals of phenol red 
absorbance and a lesser influence that would result from CO2 evolution. Low buffer 
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capacity of the medium increased its sensitivity to minor changes in acidification rate. 
Moreover, a higher initial pH of 7.7 (rather than 7.4) for test medium at the start of the 
experiment provided a wider measurement space before reaching the shoulder of the 
buffer near a pH of 6.9-7.2. Third, variations of acidification rates due to differences in 
cell number and spatial distribution were decreased by scanning each well at 25 locations. 
As demonstrated in figures 2.2 and 2.3, the assay provides a quite precise measure of 
changes in extracellular pH's and acidification rates. 
Five chemicals with well-characterized metabolic effects were used to 
demonstrate the acidification rate assay. Some of the chemicals’ most distinct interactions 
with intracellular metabolic pathways were shown in figure 2.5. DNP is an uncoupling 
agent that acts as a proton ionophore to dissipate the proton gradient across the 
mitochondrial membrane.31,34-37 Rotenone and antimycin A inhibit oxidative 
phosphorylation by inhibiting complex I and III respectively, where antimycin A has 
been reported to cause excess lactate production.33,38 Sodium fluoride is known to inhibit 
glycolysis by interfering with the enzyme enolase.32,39 Sodium oxamate has been reported 
to inhibit glucose consumption and lactate production by acting on lactate 
dehydrogenase.40 Uncoupling ATP production from oxidative phosphorylation and 
blocking oxidative phosphorylation pathway are expected to result in low efficiency of 
energy production. Reduced energy production might be compensated through increased 
glycolysis and increased production of lactate.36,38,41 Conversely, inhibition of glycolysis 
is expected to result in decreased glucose and lactate metabolic rates. Indeed, the 
observed changes in metabolism witnessed in our acidification results for DNP, AA, 
rotenone, oxamate, and fluoride correspond well with that expected from their established 
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mechanisms of action. DNP, rotenone and AA caused increases in acidification, and 
oxamate and fluoride caused decreases. While higher concentrations of AA deviated from 
our expectations, this might be due to the initiation of cell death that is not visible until 6-
hours. 
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Fig 2.5. Interaction sites for DNP, AA, fluoride, rotenone, and oxamate on metabolic 
pathways.  DNP uncouples ATP production from mitochondrial respiration. Antimycin A 
and rotenone inhibit complex III and I respectively in the electron transport chain. 
Fluoride inhibits the enzyme enolase in glycolysis. Oxamate inhibits lactate 
dehydrogenase.  Abbreviations: AcCoA = Acetyl-CoA; ADP = adenosine diphosphate; 
ATP = adenosine triphosphate; AA = antimycin A; Cyt = Cytochrome C; CI = Complex 
I; CIII = Complex III; CIV = Complex IV; DNP = 2,4-dinitrophenol; Glc = Glucose; Lac 
= lactate; NADH = Nicotinamide Adenine Dinucleotide; PEP = Phosphoenolpyruvate; 
2PG = 2-phosphoglycerate; Pyr = Pyruvate; TCA cycle = tricarboxylic acid cycle; Q = 
coenzyme Q. 
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While this method provides relatively fast quantitative data regarding the effects 
of chemicals on gross metabolic function of cells, it is really intended as a way to screen 
cells, media, and/or compounds for metabolic activity. Elucidation of the meaning behind 
acidification rate changes during a 90-min screen of an in vitro cell culture in a "test 
medium" will require further analysis. Ascertaining a working concentration range in 
regard to metabolic activity could constitute a resource-saving first step in the analysis of 
a vast variety of compounds, ranging from environmental pollutants to novel compounds 
of potential therapeutic value. Results from metabolic screens such as these should help 
in the design of subsequent experiments that employ more sophisticated tools to better 
document the effect of a compound. Thus far, this assay for metabolic activity has been 
successful in quickly identifying working ranges, which were otherwise unavailable for 
cell culture systems of cell lines, media, and compounds that were new and not 
necessarily documented in regard to metabolic activity. When correlated with traditional 
clinical or toxicological endpoints, a high-throughput metabolic screen might also be able 
to provide high content information regarding the efficacy or toxicology of test 
compounds. 
In contrast to other commonly used cytotoxicity assays which generally require 
reagent addition and additional incubation time, acidification rate assay by measuring 
absorbance of phenol red, which is a regular component of the medium, avoids the 
interference of assay reagent on cells and is more amenable to be adapted to HTS. 
Moreover, avoiding reagent addition and additional incubation time also saves time 
which allow for rapid screening. However, the inherent characteristic of the assay limits 
its application for long term evaluation of toxicity due to two reasons: first, buffer 
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capacity of the medium will disguise the chemical impact when pH of the medium is 
within the action range of a buffer; second, the very low pH due to acid production over a 
long time period will perturb cells and distort the impact of the compound. Thus, some 
degree of caution should be given for application of this assay. 
 
References 
 
 
1. Fry, J.R. (2000). Cytotoxicity and mechanistic studies in high throughput toxicity 
screening, pp. 31-42. In Approaches to High Throughput Toxicity Screening. 
Taylor & Francis, London, UK. 
2. Blaauboer, B.J. (2001). Toxicodynamic modelling and the interpretation of in 
vitro toxicity data. Toxicol Lett 120, 111-123. 
3. Atterwill, C.K. and M.G. Wing. (2002). In vitro preclinical lead optimisation 
technologies (PLOTs) in pharmaceutical development. Toxicol Lett 127, 143-151. 
4. Eisenbrand, G., B. Pool-Zobel, V. Baker, M. Balls, B.J. Blaauboer, A. Boobis, A. 
Carere, S. Kevekordes, J.C. Lhuguenot, R. Pieters and J. Kleiner. (2002). 
Methods of in vitro toxicology. Food Chem Toxicol 40, 193-236. 
5. Zucco, F. and A.L. Vignoli. (1998). In vitro toxicology in Europe 1986-1997 - 
Final report to the European Commission DGXI Financial Contribution no. B4-
3040/96/424/DEB/E2. Toxicol Vitro 12, 739-+. 
6. Zucco, F., I. De Angelis, E. Testai and A. Stammati. (2004). Toxicology 
investigations with cell culture systems: 20 years after. Toxicol Vitro 18, 153-163. 
7. Evans, S.M., A. Casartelli, E. Herreros, D.T. Minnick, C. Day, E. George and C. 
Westmoreland. (2001). Development of a high throughput in vitro toxicity screen 
predictive of high acute in vivo toxic potential. Toxicol Vitro 15, 579-584. 
8. Cree, I.A. and P.E. Andreotti. (1997). Measurement of cytotoxicity by ATP-based 
luminescence assay in primary cell cultures and cell lines. Toxicol Vitro 11, 553-
556. 
9. Slater, K. (2001). Cytotoxicity tests for high-throughput drug discovery. Current 
Opinion in Biotechnology 12, 70-74. 
10. Bradbury, D.A., T.D. Simmons, K.J. Slater and S.P.M. Crouch. (2000). 
Measurement of the ADP : ATP ratio in human leukaemic cell lines can be used 
 36
as an indicator of cell viability, necrosis and apoptosis. J Immunol Methods 240, 
79-92. 
11. O'Brien, J., I. Wilson, T. Orton and F. Pognan. (2000). Investigation of the 
Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell 
cytotoxicity. Eur J Biochem 267, 5421-5426. 
12. Slaughter, M.R., P.J. Bugelski and P.J. O'Brien. (1999). Evaluation of Alamar 
Blue reduction for the in vitro assay of hepatocyte toxicity. Toxicol Vitro 13, 567-
569. 
13. Jauregui, H.O., N.T. Hayner, J.L. Driscoll, R. Williamsholland, M.H. Lipsky and 
P.M. Galletti. (1981). Trypan Blue-Dye Uptake and Lactate-Dehydrogenase in 
Adult-Rat Hepatocytes - Freshly Isolated Cells, Cell-Suspensions, and Primary 
Monolayer-Cultures. In Vitro-Journal of the Tissue Culture Association 17, 1100-
1110. 
14. Trohalaki, S., R.J. Zellmer, R. Pachter, S.M. Hussain and J.M. Frazier. (2002). 
Risk assessment of high-energy chemicals by in vitro toxicity screening and 
quantitative structure-activity relationships. Toxicol Sci 68, 498-507. 
15. Chiba, K., K. Kawakami and K. Tohyama. (1998). Simultaneous evaluation of 
cell viability by neutral red, MTT and crystal violet staining assays of the same 
cells. Toxicol Vitro 12, 251-258. 
16. Green, L.M., J.L. Reade and C.F. Ware. (1984). Rapid Colormetric Assay for Cell 
Viability - Application to the Quantitation of Cyto-Toxic and Growth Inhibitory 
Lymphokines. J Immunol Methods 70, 257-268. 
17. Putnam, K.P., D.W. Bombick and D.J. Doolittle. (2002). Evaluation of eight in 
vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicol 
Vitro 16, 599-607. 
18. Wodnicka, M., R.D. Guarino, J.J. Hemperly, M.R. Timmins, D. Stitt and J.B. 
Pitner. (2000). Novel fluorescent technology platform for high throughput 
cytotoxicity and proliferation assays. J Biomol Screen 5, 141-152. 
19. Valentin, I., M. Philippe, J.C. Lhuguenot and M.C. Chagnon. (2001). Uridine 
uptake inhibition as a cytotoxicity test for a human hepatoma cell line (HepG2 
cells): comparison with the neutral red assay. Toxicology 158, 127-139. 
20. Cao CJ, M.R., Menking DE, Valdes JJ, Cortes VI, Eldefrawi ME, Eldefrawi AT. 
(1997). Validation of the cytosensor for in vitro cytotoxicity studies. Toxicol Vitro 
11, 285-293. 
21. Hafner, F. (2000). Cytosensor((R)) Microphysiometer: technology and recent 
applications. Biosens Bioelectron 15, 149-158. 
 37
22. Bousse, L. (1996). Whole cell biosensors. Sens Actuator B-Chem 34, 270-275. 
23. Cooke, D. and R. O'Kennedy. (1999). Comparison of the tetrazolium salt assay 
for succinate dehydrogenase with the cytosensor microphysiometer in the 
assessment of compound toxicities. Anal Biochem 274, 188-194. 
24. Cao CJ, E.M., Eldefrawi AT, Burnett JW, Mioduszewski RJ, Menking DE, 
Valdes JJ. (1998). Toxicity of sea nettle toxin to human hepatocytes and the 
protective effects of phosphorylating and alkylating agents. TOXICON 36, 269-
281. 
25. Cao CJ, M.R., Menking DE, Valdes JJ, Katz EJ, Eldefrawi ME, Eldefrawi AT. 
(1999). Cytotoxicity of organophosphate anticholinesterases. IN VITRO 
CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL 35, 493-500. 
26. Wille, K., L.A. Paige and A.J. Higgins. (2003). Application of the Cytosensor 
(TM) microphysiometer to drug discovery. Receptors & Channels 9, 125-131. 
27. CRC press, c., OH. (2000/01). In CRC handbook of chemistry and physics. CRC 
Press, Cleveland, OH. 
28. Balcarcel, R.R. and L.M. Clark. (2003). Metabolic screening of mammalian cell 
cultures using well- plates. Biotechnol Prog 19, 98-108. 
29. Girard, P., M. Jordan, M. Tsao and F.M. Wurm. (2001). Small-scale bioreactor 
system for process development and optimization. Biochem Eng J 7, 117-119. 
30. John, G.T. and E. Heinzle. (2001). Quantitative screening method for hydrolases 
in microplates using ph indicators: Determination of kinetic parameters by 
dynamic pH monitoring. Biotechnol Bioeng 72, 620-627. 
31. Linsinger, G., S. Wilhelm, H. Wagner and G. Hacker. (1999). Uncouplers of 
oxidative phosphorylation can enhance a Fas death signal. Mol Cell Biol 19, 
3299-3311. 
32. Niknahad, H., S. Khan, C. Sood and P.J. Obrien. (1994). Prevention of Cyanide-
Induced Cytotoxicity by Nutrients in Isolated Rat Hepatocytes. Toxicol Appl 
Pharmacol 128, 271-279. 
33. Zhang, J.G., M.A. Tirmenstein, F.A. Nicholls-Grzemski and M.W. Fariss. (2001). 
Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent 
and -independent cell death: Protective role of antioxidants. Arch Biochem 
Biophys 393, 87-96. 
34. Sibille, B., C. Filippi, M.A. Piquet, P. Leclercq, E. Fontaine, X. Ronot, M. 
Rigoulet and X. Leverve. (2001). The mitochondrial consequences of uncoupling 
intact cells depend on the nature of the exogenous substrate. Biochem J 355, 231-
235. 
 38
35. Sibille, B., X. Ronot, C. Filippi, V. Nogueira, C. Keriel and X. Leverve. (1998). 
2,4 dinitrophenol-uncoupling effect on Delta Psi in living hepatocytes depends on 
reducing-equivalent supply. Cytometry 32, 102-108. 
36. Khayat, Z.A., T. Tsakiridis, A. Ueyama, R. Somwar, Y. Ebina and A. Klip. 
(1998). Rapid stimulation of glucose transport by mitochondrial uncoupling 
depends in part on cytosolic Ca2+ and cPKC. American Journal of Physiology-
Cell Physiology 44, C1487-C1497. 
37. Leverve, X., B. Sibille, A. Devin, M.A. Piquet, P. Espie and M. Rigoulet. (1998). 
Oxidative phosphorylation in intact hepatocytes: Quantitative characterization of 
the mechanisms of change in efficiency and cellular consequences. Molecular and 
Cellular Biochemistry 184, 53-65. 
38. Tiefenthaler, M., A. Amberger, N. Bacher, B.L. Hartmann, R. Margreiter, R. 
Kofler and G. Konwalinka. (2001). Increased lactate production follows loss of 
mitochondrial membrane potential during apoptosis of human leukaemia cells. Br 
J Haematol 114, 574-580. 
39. Kerai, M.D.J. and J.A. Timbrell. (1997). Effect of fructose on the biochemical 
toxicity of hydrazine in isolated rat hepatocytes. Toxicology 120, 221-230. 
40. Sanfeliu, A., C. Paredes, J.J. Cairo and F. Godia. (1997). Identification of key 
patterns in the metabolism of hybridoma cells in culture. Enzyme Microb Technol 
21, 421-428. 
41. Pilatus, U., E. Aboagye, D. Artemov, N. Mori, E. Ackerstaff and Z.M. Bhujwalla. 
(2001). Real-time measurements of cellular oxygen consumption, pH, and energy 
metabolism using nuclear magnetic resonance spectroscopy. Magnetic Resonance 
in Medicine 45, 749-755. 
 
  
 
 39
CHAPTER III 
 
 
DETERMINATION OF CARBON DIOXIDE PRODUCTION RATES FOR 
MAMMALIAN CELLS IN A SEALED 24-WELL PLATE 
 
 
 
Abstract 
This work describes a high throughput method for quantitative determination of 
carbon dioxide production rates of mammalian cells in 24-well plate format. Gas-liquid 
mass transfer of CO2 produced by the cells is simulated in a sealed system with variable 
pH, which guides the design of custom-made, reusable, optically clear plugs to seal the 
wells of a 24-well plate. These plugs prevent the loss of CO2 produced by the mammalian 
cells cultured in bicarbonate-free medium. Measurements of pH, total liquid phase CO2, 
and viable cell density are used to estimate the average CO2 production rate during a 6-
hour incubation period. The method is demonstrated using fibroblast cells treated with 
four chemicals that are known to act on mitochondria: 2,4-dinitrophenol, antimycin A, 
rotenone, and cyanide. Significant changes in CO2 production were observed for given 
concentrations of the chemicals within 6-h and without a decline in culture viability. 
Similar concentrations of chemicals corresponded with growth inhibition over longer 
times but not with cell death. An assay based on metabolic change corresponding to 
growth inhibition that is more sensitive than traditional measure of cell death is a feasible 
complement to existing methods in drug discovery and toxicity testing. 
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Introduction 
Research in metabolic engineering, cell culture process, and drug discovery all 
involve studies of cellular responses to culture environment, biochemical molecules, and 
drugs. Rates of metabolic reactions are the bases for many cellular physiological 
functions, including growth, death, and generation of energy. Studies of the metabolic 
status of cells often involve parameters such as glucose, lactate, pH, CO2 and oxygen, 
changes in which are relevant to major metabolic pathways such as glycolysis, the TCA 
cycle, and oxidative phosphorylation. CO2 is a major product of mammalian cell 
metabolism and is produced in many biochemical reactions, chiefly the pentose 
phosphate pathway and the citric acid cycle. Thus, measurement of CO2 produced by 
mammalian cells can provide a complementary measure of changes in central carbon 
metabolism and mitochondrial function. 
A lot attention has focused on the determination and control of CO2 in 
mammalian cell culture process due to its impact on growth rate, product production rate 
and quality, intracellular pH, and apoptosis.1-6 Historically, CO2 production rate of 
mammalian cells could not be easily monitored because of the solution/dissolution of 
carbon dioxide in the culture medium and small amount of CO2 produced compared to 
microbial cultures.4 In addition, the use of NaHCO3 buffer for most animal cell culture 
process further complicates the measurement of CO2 production rate because a 
substantial CO2 converted from them may mask the contribution of CO2 that produced by 
cells.4,7 Currently, quantitative determination of CO2 production rates is feasible only in 
bioreactors equipped with mass spectrometers or gas analyzers for gas phase mole 
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fraction determinations and CO2 probes and/or blood gas analyzers for total liquid phase 
CO2.4-10 None of them has been in a format readily amenable for high-throughput usage.  
In this work, I made novel sealing plugs for a 24-well plate system and a 
corresponding method that allows for measurement of CO2 production rates of 
mammalian cell cultures. The method is demonstrated using fibroblast cells treated with 
four chemicals that are known to act on mitochondria: 2,4-dinitrophenol, antimycin A, 
rotenone, and cyanide.11-14 Presumably, perturbation of mitochondrial function and the 
indirect effect on the rate of oxidation of metabolic substrates would be manifested in 
changes in CO2 production. The method presented in this paper provides a faster, 
cheaper, multi-replicate, and comparably quantitative way to determine CO2 production 
rates of mammalian cells. It is applicable to suspension as well as adherent cell lines and 
is useful for screening volatile compounds too. It will be of use in various fields such as 
cell culture engineering, metabolic engineering, toxicology, and drug discovery and drug 
development. 
 
Materials and methods 
Modeling gas-liquid mass transfer of CO2 produced by cells 
To guide the design for measurement of CO2 production rate, a model was set up 
to describe the mass transfer of CO2 within liquid and gas phase in open and sealed batch 
culture system. In a sealed system, the carbon dioxide produced by cells will exist in the 
liquid phase as dissolved CO2 in equilibrium with bicarbonate and carbonate or in the gas 
phase as gaseous CO2.  It should be noted that only CO2 could be exchanged with the gas 
phase. 
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−+−− +→←+→←→←+ → 2333222 22 COHHHCOCOHOHCOcell COq (3-1) 
At a temperature of 37 °C and a pH value of approximately 7 under regular cell culture 
conditions, less than 0.5% of the dissolved CO2 is presented as H2CO3 and almost none as 
−2
3CO .
6 Thus, both species are neglected and the equilibrium reaction can be simplified 
as: 
+− +→←+→ HHCOOHCOcell COq 3222    (3-2) 
At known pH, CO2 and −3HCO are in equilibrium according to: 
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        (3-3) 
where 
2CO
C  is the dissolved CO2 concentration, AC  is the sum of liquid concentration of 
2CO
C and −
3HCO
C , and 
2CO
K is the dissociate equilibrium constant.  
Due to the high mass transfer coefficient of CO2 in the gas phase, the 
concentration of CO2 in the gas phase is in relatively rapid equilibrium with the CO2 
concentration in the gas liquid interphase ( *
2CO
C ) according to Henry’s law:  
*
2CO
HCPy =         (3-4) 
The CO2 transfer between liquid and gas phases can be described by two mass balance 
equations.7 In liquid phase, the AC  balance for a batch culture becomes: 
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For gas phase, the mass balance can be described as: 
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* −−=      (3-6) 
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For a system with variable pH, CO2 transfer also depends on the pH and buffer capacity 
of the liquid phase. Both CO2 and lactate produced by cells contribute the acid production 
for change in pH of liquid phase as shown in equation 3-1 and 3-7.  
+− +→→ HLacLactatecell lacq     (3-7) 
In the liquid phase containing buffer, the buffer will quench a portion of the protons. 
HBHB
buffer
aK  →←+ +−        (3-8) 
Since the change in concentration of protons consumed by or produced from each species 
is equal to its dissociated basic species, the differential change of proton concentration in 
liquid can be expressed as: 
−−−+ ++= BHCOLacH dCdCdCdC 3       (3-9) 
From the dissociated reaction equilibrium, the concentration of dissociated basic species 
is dependent on total concentration of buffer and pH: 
BH
BtotB
B KC
CKC += +−
−         (3-10) 
where total buffer concentration ( BtotC − ) is the sum of concentration of HB and its 
dissociated basic species −B . Derivative yields equation:  
+
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− +−+=
−
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B
B dCKC
KCdC
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    (3-11) 
Total concentration of buffer is constant, thus 
+
+
− +−=
−
H
BH
BtotB
B dCKC
CKdC 2)(
      (3-12) 
Lactate and CO2, however, are functions of time: 
dtqndC lacvlactot =−         (3-13) 
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and 
dtqndC COvCOtot 22 =−         (3-14) 
where lactotC − and 2COtotC − are total lactate and CO2 concentrations, lacq  and 2COq are the 
lactate production rate and CO2 production rate, respectively. Substitution of equations 3-
13 and 3-14 into 3-11 to get −
3HCO
dC  and −lacdC , and then substitution of 3-12 into 3-10 
to finally yields equation 3-15, after rearrangement. 
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where iK  represents the dissociation constant of bicarbonate, lactate and buffer; itotC −  
represents the total concentrations of three species. The medium for CO2 production rate 
assay is buffered with Hepes. Other components of the medium, such as phenol red and 
amino acids, are also buffers. Their buffer capacity is neglected due to either their 
concentrations are low or their pKa’s are out of the range of the pH of the medium under 
culture condition. A combination of mass balance equations for CO2 and protons with 
phase equilibrium equations allows for calculation of dynamic changes of CO2 in gas and 
liquid phases and pH in liquid phase. Dissociation constants and the Henry’s law constant 
are from literature.15,16 The apK values used here are 6.138, 3.86, and 7.5 for 
−
3HCO , 
lactate, and Hepes, respectively. Henry’s law constant of CO2 is 4.20×6 Pa.m3.mmol-1. 
kla is determined experientially to be 28.2 hr-1. vn  is 1.5×106 cells/mL and lacq  and 
2CO
q are estimated to be 3×10-10 and 1×10-10 mmol/cell/hr, respectively, based on cells 
growing at regular culture condition. Coupled normal differential equations are solved 
numerically in Matlab. 
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Cell culture and media 
Mouse fibroblast cells (CRL-10225) were obtained from ATCC (Manassas, VA, 
USA). During routine maintenance, cells are grown in T-75 cm2 flasks (VWR 
International, Inc., Suwanee, GA, USA) placed in an incubator (Forma Scientific, Inc., 
Marietta, OH, USA) controlled at 37°C, 95% humidity, and 10% CO2. Maintenance 
medium consists of DMEM (Mediatech, Herndon, VA, USA) supplemented with 10% 
fetal bovine serum (Sigma Chemical Co. St. Louis, MO, USA), 10 U/ml penicillin–10 
µg/mL streptomycin (Sigma Chemical Co.), and 4 mM L-glutamine (Mediatech). This 
medium contains 25 mM D-glucose and is buffered with 3700 mg/L of sodium 
bicarbonate. Medium used during cell attachment prior to the start of a CO2 production 
rate ("pretest" medium) consists of bicarbonate-free/glucose-free RPMI 1640 medium 
containing 2.05 mM glutamine (Sigma Chemical Co.). It is supplemented with 10% fetal 
bovine serum, 25 mM D-glucose, 10 U/mL penicillin–10 µg/mL streptomycin, and 50 
mM Hepes (Sigma Chemical Co.). Medium used during the CO2 production rate assay 
("CPR-test" medium) is the same as pretest media, with the exceptions of substituting10 
mg/L insulin and 5 mg/L holo-transferrin for serum, reducing glucose to 5.0 mM, and 
increasing phenol red to 30.0 mg/L for the spectrophotometric pH measurement (all from 
Sigma Chemical Co.).  
Test chemicals 
2,4-dinitrophenol (DNP), antimycin A, rotenone and potassium cyanide were 
purchased from Sigma Chemical Co. Concentrated stocks of DNP, antimycin A, and 
rotenone were made in ethanol, whereas a concentrated stock of potassium cyanide was 
made in sterilized water. Test media for control and 5 different concentrations of a 
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chemical received the necessary amount of concentrated stock, as well pure solvent so 
that the final concentration of solvent in every medium was 1% (vol/vol). 
Sealing plugs for the 24-well plate CO2 production rate assay 
Determination of CO2 production rates was accomplished in 24-well plates (BD 
Biosciences, Benford, MA, USA) sealed with custom-made plugs (Figure 3.1). The plugs 
were milled from clear polycarbonate plastic rods by the Vanderbilt science machine 
shop and fitted with Viton® O-rings (McMaster, Atlanta, GA, USA). The O-rings are 
under slight tension when placed in the groove near the top of the plug, causing their 
outer diameter match that of the well near its opening. When inserted into a well filled 
with 0.50 mL of culture, a plug reduces the headspace volume in a well to 1.10 mL. The 
plugs are inserted by pushing softly until the O-ring is just within the top of the well. 
Prior to use in an experiment, the plugs are sterilized using 70% isopropyl alcohol (Sigma 
Chemical Co.). 
pH measurement 
The pH of each sealed well at the end of a CO2 production rate test is determined 
prior to unsealing it by measuring the absorbance of the pH indicator, phenol red, using a 
method described previously in chapter II.17 Absorbance readings for pH measurement 
were performed on an FL 600 plate reader (Bio-Tek Instruments, Winooski, Vermont, 
USA) with temperature controlled at 37°C. To correct for variations in plug clarity, 
condensation, and well plate background, an absorbance at A720 is taken and subtracted 
from one at A562. Furthermore, the mean of absorbance of scans at twenty-five distinct 
locations per well is used to reduce variation of cell coverage. The net absorbance is 
converted to pH using a calibration line constructed in advance, and the estimated error in 
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the pH measured using this method is less than 0.03 pH units. For all experiments 
conducted, the pH of a given well and chemical concentration decreased from 7.3 
initially to a minimum of 6.8. 
 
 
Figure. 3.1. Sealed well-plate system for CO2 production rate assay. (A) Side view 
section of well sealed with a plug. (B) Side view of a polycarbonate plug. (C) Top view 
of Viton O-ring. (D) Side view section of a well dimensions; also shown are the width of 
O-ring and width of the well at the O-ring’s point of contact. 
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Enzymatic assay for total liquid phase CO2 
The total liquid phase CO2 (dissolved CO2 and −3HCO ) for each well of a 24-well 
plate is determined by enzymatic assay. The enzymatic assay is based on an original 
Sigma recipe developed by Forrester.18 In this assay, phosphoenol pyruvate is converted 
to malate in two reactions catalyzed by phosphoenol pyruvate carboxylase (Calbiochem-
Novabiochem Corp., La Jolla, CA, USA) and malic dehydrogenase (Sigma Chemical 
Co.). 
−− +→+ 423 POHteOxaloacetalpyruvatePhosphoenoHCO
PEPC
   (3-16) 
++→+ NADMalateNADHteOxaloaceta MDH    (3-17) 
The first reaction requires a stoichiometric proportion of bicarbonate. The second 
reaction consumes the intermediate oxaloacetate while concomitantly consuming NADH 
(β-nicotinamide adenine dinucleotide reduced disodium salt hydrate, Sigma Chemical 
Co.), which is detected by loss of absorbance. We reconstructed the assay to increase its 
precision for concentrations in the range of 0.0 to 4.0 mM total CO2 and to optimize 
absorbance reading from a 96-well plate instead of cuvettes. The new recipes are as 
follows: the buffer solution is comprised of 100 mM Tris buffer and 10 mM magnesium 
chloride (Sigma Chemical Co.), at a pH of 8.5; reagent A contains 37.3 mM PEP (Sigma 
Chemical Co.) and 4.7 mM NADH in buffer solution; and reagent B contains 11200 U/L 
MDH and 22400 U/L PEPC in buffer solution. 
To conduct the assay, an appropriate number of wells of a 96-well plate (VWR 
International, Inc) are pre-filled with 120 µL of reagent A. Then, triplicate 70 µL 
volumes of standards (sodium bicarbonate in distilled water, Sigma Chemical Co.) and 
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test samples are added to each well. Test samples are obtained from the 24-well plate by 
unplugging each well one at a time. The initial absorbencies of the wells are read at 375 
nm using a µ-Quant UV/vis plate reader (Bio-Tek Instruments) at room temperature. 
Then, 10 µL of reagent B is added to each well, the plate is incubated for 15 minutes at 
room temperature, and the final absorbencies are determined at 375 nm. 
Determination of CO2 production rates of fibroblast cell cultures treated with 
chemicals 
 
Fibroblast cells harvested from T-75 cm2 flasks are centrifuged at 200g for 10 
minutes and resuspended in pretest medium at a cell density of 1.5x106 cells/mL. 500 µL 
of this culture are seeded into wells of three rows of the 24-well plate, where a first row is 
reserved as cell-free. The well plate is then incubated in an oven (VWR International, 
Inc.) with ambient levels of CO2 at 37 °C for 10 hours to allow cell attachment. Next, 
pretest medium is removed; all wells are washed twice with PBS (phosphate-buffered 
saline, Mediatech) and 500 µL of test media containing specific chemical concentrations 
is added to each well of one column, including the cell-free well. Each well of the plate is 
sealed by manual application of the plugs and incubated in the oven for 6 hours at 37 °C. 
At the end of the incubation period, absorbencies at 562 nm and 720 nm are read. Finally, 
each well is opened, immediately sampled in triplicate, and samples added into a 96-well 
plate prepared with CO2 assay reagent. After sampling, cell number and viability are 
determined for one well of each column (of each chemical concentration) by 
hemocytometer with trypan blue staining. 
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Calculation of CO2 production rates 
The actual measured quantity in the enzymatic assay is AC , the sum of dissolved 
CO2 ( 2COC ) and bicarbonate ( −3HCOC ). After pH and AC  are determined for each well, 
dissolved CO2 can be calculated using dissociated equilibrium equation 3-3. For gas-
liquid systems at equilibrium, as shown in equation 3-4, Henry’s law adequately 
describes the relationship between gas liquid interphase equilibrium ( *
2CO
C ) and 
2CO
y , the 
mole fraction in the headspace of a well. With a large mass transfer rate of CO2 of 28.2 
hr-1 (experimentally determined), it is reasonable to assume equilibrium between liquid 
and gas phase CO2 and to use the bulk concentration in the Henry’s law expression. Thus, 
the fraction of CO2 ( 2COy ) in headspace can be calculated using equation 3-4 based on 
calculated dissolved CO2. Finally, total CO2 ( totC ) present in the well can be expressed as 
the total amount of CO2 existing in gas plus the liquid phases divided by the culture 
volume, which is shown in equation 3-18 after rearrangement. 
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Values of dissociation constant K and Henry’s law constant were same as used in the 
CO2 transfer simulation. The value of R used in the calculation is 8.31×103 Pa.L/mol/K. 
The average CO2 production rate for each well during the exposure interval is 
calculated as the difference of endpoint total CO2 content of wells with cells and cell-free 
wells, divided by the viable cell density and time interval (Equation 3-19). 
tn
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The viable cell density used is the average of initially seeded viable cell density 
and final viable cell density determined by the trypan blue count, neglecting growth 
during 10 hours of attachment. 
Additional assays for culture viability 
The viabilities of fibroblast cultures exposed to the chemicals were further 
assessed using separate experiments in unsealed 24-well plates during 6- and 24-h 
incubations. Here, culture viability was determined using MTT (Sigma Chemical Co.) 
and resazurin (Sigma Chemical Co; also known as Alamar BlueTM) assays. The resazurin 
reagent was prepared at a concentration of 0.0105%.19 The pre-test medium for these 
viability tests was the same as the pre-test medium used prior to the CO2 production rate 
assay. Media during 6-h incubations was the same as the CPR-test media, with the 
exception of having a standard amount of phenol red (5.3 mg/L) to avoid interference 
with the MTT and resazurin readings. Medium for 24-h incubations was the same as 
media for 6-h incubations, with the exception of having 25 mM glucose. 
Growth of fibroblast cell cultures treated with chemicals 
The effects of chemicals on cell growth were determined in 6-well plate (VWR 
International, Inc.) experiments. Prior to adding medium with chemicals, the cells were 
placed into wells at a density of 2×105 viable cells/mL and allowed to attach by 
incubating in maintenance medium for 10 hours in an incubator controlled at 37 °C, 95% 
humidity, and 10% CO2. Then, maintenance medium was removed, cells were washed 
with PBS, and growth-test medium containing a specific concentration of a chemical was 
added to the cultures. Cell growth was followed for 6 days. Each day and for each 
concentration tested, one well was sacrificed for a cell count of both adherent and 
 52
detached cells using the trypan blue exclusion method. Medium used for these assays 
consisted of bicarbonate-free and glucose-free RPMI 1640 medium containing 2.05 mM 
glutamine and supplemented with 25.0 mM D-glucose, 10% fetal bovine serum, 10U/mL 
penicillin-10 µg/mL streptomycin, and 2000 mg/L of sodium bicarbonate. This 
formulation differs from CPR-test medium in glucose content and buffering in order to 
allow for longer-term monitoring of cultures.7 
Statistical analysis 
Statistical significance at the 95% confidence level of differences between test 
and control cultures was compared using a Dunnett’s test in software JMPIN™ 
(DUXBURY, Pacific Grove, CA, USA). 
 
Results 
Simulated dynamic change of CO2 concentration in the liquid and gas phase 
The CO2 production rate assay is designed under the direction of simulated mass 
transfer of CO2 between liquid and gas phase. The mass transfer coefficient of CO2 used 
for the model is determined experimentally by simultaneously monitoring CO2 release 
and pH change of test medium in open well plate, which initial CO2 concentration is 
obtained by equilibrating with 10% CO2 in the incubator. The simulated dynamic 
changes of total liquid phase CO2 concentration and mole percentage of CO2 in the gas 
phase are shown in figure 3.2. In open condition, the accumulated CO2 concentration in 
the liquid phase is less than 0.10 mM at all times, and the mole percentage of CO2 
released into the air increases up to over 90% at 10 hr incubation. In contrast, in sealed 
condition, the total liquid phase CO2 concentration accumulate appreciably in a linear 
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fashion, up to 0.87 mM and 1.20 mM at 10 hr for headspace at volume of 3 mL and1.0 
mL, respectively. The percentage of CO2 released into the gas phase also increases 
slightly with the accumulation of CO2 in the liquid phase, and the percentage is up to 
40% and 20% for headspace at volume of 3 mL and1.0 mL. In comparison of the effect 
of the volume of headspace, more CO2 is accumulated in the liquid phase with reduced 
volume of headspace. Since the enzyme assay measures the total liquid phase CO2 
concentration, therefore, the culture system needs to be sealed with a reduced volume of 
headspace for clearer signal. Moreover, the amount of CO2  in the gas phase is significant 
and needs to be taken account for accurate determination of CO2 production rate. 
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Fig. 3.2. Simulated distribution of CO2 produced by cells in liquid phase and gas phase in 
open and sealed conditions. Solid lines and markers represent dynamic changes of total 
liquid phase CO2 concentration in open (S) and sealed conditions with the volume of 
headspace at 1 mL (♦) and 3 mL (g). Dashed lines corresponds to the percentage of CO2 
produced by cells (mol/mol) released to gas phase in open (U) and sealed conditions with 
the volume of headspace at 1 mL (◊) and 3 mL ( ). 
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Accumulation of CO2 in plug-sealed wells  
Based on the simulated results, plugs were designed to seal the wells to reduce the 
volume of headspace at volume of 1.10 mL. To verify the design and optimize the 
incubation time, the total liquid phase CO2 concentrations of wells containing 500 µL of 
fibroblast culture in sealed condition were analyzed at the end of 2-, 4-, 6-, 8- and 10-hr 
intervals and compared to the results obtained in open condition. As shown in figure 3.3, 
wells that were left open only reached a total liquid phase CO2 concentration of 0.08 mM 
at all times. In contrast, wells that were sealed with the custom-made plugs demonstrated 
a fairly linear increase in CO2 accumulation, up to 1.2 mM at 10 hours. The results 
agreed with those predicted from modeling. 
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Fig. 3.3. Measurement of total liquid phase CO2 in open and sealed-well fibroblast cell 
cultures.  Total liquid phase CO2 measured at the end of a time interval for open wells 
(black bar), plug-sealed wells (gray bars), and an independent replicate experiment for 
plug-sealed wells (white bars). Results are the average and standard deviation of 
measurements from three separate wells. 
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The well headspace volume of the current design is small enough to allow CO2 to 
accumulate appreciably for clear signal. As predicted from modeling, the increase in CO2 
accumulation in the liquid phase can be obtained by further reducing the volume of 
headspace. However, this is not achievable because bigger size of the plug will contact 
the medium and interfere with the pH measurement. Moreover, too small headspace 
might cause oxygen depletion which will perturb metabolic status of cells. To verify that 
the oxygen is not limited under current design, the metabolic statuses of fibroblast cells 
cultured in the open and sealed conditions are compared by measuring glucose uptake 
and lactate production over 10 hr incubation. As shown in figure 3.4, there is no 
significant difference observed between results obtained in sealed and open condition for 
both glucose uptake and lactate production. 
The loss of CO2 during opening of plug and sampling of supernatant is also one 
factor which can affect the accuracy for determination of CO2 production rate. The 
procedures of plug opening and supernatant sampling can be accomplished in a less than 
10 seconds. The loss of CO2 in such a short period is verified to be negligible based on 
the mass transfer experiments (not shown). The concentrations of accumulated CO2 in the 
liquid phase over 6 hr are sufficient to detect the difference and the signal-to-noise ratio 
is acceptable. In a batch system, significant changes in extracellular environment will 
affect the precision of average metabolic rates. Thus, short incubation period is preferred 
and 6-hr interval is used for subsequent exposure experiments. 
 
 
 
 
 
 56
(A) 
0.00
1.00
2.00
3.00
4.00
5.00
0 2 4 6 8 10
Time Interval (hr)
G
lu
co
se
 C
on
su
m
pt
io
n 
(m
M
)
 
(B) 
0.00
1.00
2.00
3.00
4.00
5.00
0 2 4 6 8 10
Time Interval (hr)
La
ct
at
e 
Pr
od
uc
tio
n 
(m
M
)
 
 
Fig. 3.4. Comparison of well plate fibroblast cell culture glucose uptake and lactate 
production in open and sealed condition. Figure shows the changes in glucose (A) and 
lactate (B) concentration at the end of a time interval for open wells (white bar) and plug-
sealed wells (black bar). Results are the mean and standard deviation of measurements 
from three separate wells. 
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Estimation of headspace CO2 mole fractions 
Since the fraction of total CO2 to be found in the headspace of a plug-sealed well 
under culture conditions is about 20%, it needs to be taken account for more accurate 
determination of CO2 production rate. To verify the estimation of headspace mole 
fractions of CO2 based on measurements for pH and total liquid phase CO2, we 
equilibrated test medium in cell-free wells in a temperature-controlled CO2 incubator set 
to maintain CO2 at a particular level, which was confirmed by FYRITE Gas Analyzer 
(Bacharach, New Kensington, PA, USA). Results are shown in table 3.1 for tests 
accomplished with incubator gas phase CO2 settings of 3, 5, 7, and 10%, where incubator 
settings less than 3% were not achievable with high precision. The calculated values 
agreed sufficiently well with those set during the incubation, obviating a need to better 
define the parameters obtained from the literature. 
 
Table 3.1. Comparison of measured and calculated total liquid phase CO2. Measured 
total liquid phase CO2 and measured pH obtained from cell-free test medium in 24-well 
plates equilibrated in an incubator with fixed percentage of CO2. The estimated mole 
fraction is that calculated using equilibrium equations (with dissociation and Henry’s law 
constants from the literature) and the measured quantities. The % Difference is the 
difference of the estimated and set mole percentages divided by the set mole percentage. 
 
Incubator setting for mole 
percentage of CO2 (%) in gas phase 3.0 5.0 7.0 10.0 
Measured pH 6.3±0.01 6.27±0.01 6.20±0.03 6.16±0.03 
Measured total liquid phase CO2 
(mM) 1.69±0.05 2.68±0.05 3.91±0.03 4.50±0.21 
Estimated mole percentage (%) 2.86 4.72 7.56 9.14 
% Difference -4.6 -5.6 8.0 8.6 
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Monitoring CO2 production rates of fibroblast cell cultures exposed to four chemicals 
The developed assay was demonstrated by testing the effects of various 
concentrations of DNP, antimycin A, rotenone, and potassium cyanide on the average 
CO2 production rates of fibroblast cell cultures obtained over 6-h (Figure 3.5). DNP 
caused increases in CO2 production up to approximately 50% for all concentrations 
tested, as low as 0.02 mM. CO2 production was inhibited by 60-70% for all 
concentrations of antimycin A and rotenone tested, as low as 0.002 and 0.02 mM, 
respectively. Cyanide inhibited CO2 production by 35% to 65% for doses ranging from 
0.20 to 1.00 mM.  
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Figure 3.5. Determination of CO2 production rates for fibroblast cell cultures exposed to 
four toxic chemicals. Rates are determined at six concentrations for fibroblasts exposed 
for 6 hr to (A) DNP, (B) antimycin A, (C) rotenone, and (D) cyanide. Experiments were 
performed independently from each other. Data shown are the average and standard 
deviations of measurements from three separate wells. Culture cell density and viability 
were unchanged during the 6-hour exposure period (not shown). DNP, 2,4-dinitrophenol. 
 
 
 
Short- and long-term effects of chemicals on growth and death of fibroblast cultures 
The fibroblast cultures exposed to these chemicals showed no noticeable changes 
in cell density or culture viability at the end of the 6-h incubation as determined by cell 
counts using trypan blue (not shown). The lack of effect on viability of the cultures at 6-h 
was further confirmed in additional experiments where viability was measured by MTT 
and resazurin assays (data not shown). Decreases in culture viability at 6-h were observed 
for two chemicals, antimycin A and cyanide, when we increased their concentrations to 
0.06-0.09 mM and 5.0-20.0 mM, respectively, where the range quoted is that taken from 
both the resazurin and MTT results (Figure 3.6). Maximum achievable concentrations of 
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DNP and rotenone of 1.0 mM and 0.1 mM, respectively (based on solubility limits of 
stock solutions and the specification of 1% vol/vol final solvent concentration), were not 
high enough to cause cell death in 6 hours (not shown). 
Decreases in fibroblast culture viability (determined by a resazurin assay, not 
shown) were not observable during 24-h exposures to the same concentrations of DNP, 
antimycin A, and rotenone used in the CO2 production rate assay. We were able, 
however, to observe growth inhibition of fibroblast cultures over a 6-day period at the 
minimum concentrations of antimycin A and rotenone tested in the CO2 production rate 
assay (0.002 mM and 0.02 mM, respectively) but not for the minimum concentration of 
DNP (Figure 3.6). The effects of cyanide could not be assessed in these longer-term 
experiments due to its evolution as HCN. 
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Figure 3.6. Culture viability immediately following a 6-hr exposure. Viable cell density 
by trypan blue cell counting (solid line), relative fluorescence of resazurin assay (gray 
bars) and relative absorbance of MTT (white bars) for fibroblast cell cultures exposed to 
higher concentrations of antimycin A (A) and cyanide (B). Data for cell densities are the 
averages and standard deviations of duplicate counts from a single well of each 
concentration. Results for resazurin and MTT assays are the averages and standard 
deviations of measurements from three separate wells. Significant differences relative to 
the control culture at a 95% confidence level are denoted by asterisks. 
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Figure 3.7. Effect of chemicals on cell growth.  Cell density of control (g) and treated 
(♦) cultures. DNP (A) at 0.02 mM, antimycin A (B) at 0.002 mM, and rotenone (C) at 
0.02 mM. 
 
 
 
Discussion 
In this work, we designed a sealed system for faster, cheaper, multi-parallel, and 
quantitative determination of CO2 production rate. The design was directed by using a 
mathematic model for transfer of CO2 between gas and liquid phases which takes into 
account pH changes that affect the transfer and CO2 determination. The method hinges on 
specialized plugs for individually sealing the wells. Without plugging the wells, the total 
liquid phase CO2 concentration does not exceed 0.10 mM. Sealing the well with 
conventional sealing tapes yields a larger headspace of 3.0 ml, but the measured 
concentration is still less than 0.1 mM because the tapes can not seal the wells air tightly. 
The quality of the seal provided by the plug fitted with an O-ring was tested by placing 
plug-sealed wells into an incubator set with 10% CO2 for 6 hours and measuring that no 
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CO2 was found in the enclosed medium. Additionally, the plugs were made of optically 
clear material to allow for determination of pH prior to opening a well. The volume of the 
headspace of well was optimized to be small enough to allow CO2 to accumulate 
appreciably, but not so small as to allow oxygen depletion to occur. That oxygen was not 
limited in plugged wells was indirectly confirmed by measurement of similar glucose 
consumption and lactate production rates for cultures in sealed wells and open wells over 
ten hours of incubation. 
The CO2 production rate assay also relies on not exposing the well plate and cell 
cultures to high levels of CO2 prior to or during the assay. Clearly, standard levels of 
bicarbonate-buffer in medium would confound the measurement of the lesser amounts of 
CO2 from cellular production. In addition, during development we discovered that the 
polystyrene well plates can actually reversibly adsorb CO2 from the CO2-incubator and 
media with standard amounts of bicarbonate buffer. Thus, we used Hepes instead of 
bicarbonate as a buffer and used an oven with ambient levels of CO2 to maintain culture 
temperature. Furthermore, we determined the adsorption of CO2 produced by cells during 
an incubation period in the sealed wells is negligible (results not shown). Finally, in 
deciding a concentration for buffering, we chose a higher concentration of Hepes that 
would minimize changes in pH and allow more carbon dioxide to accumulate in the 
liquid phase as bicarbonate.6 
The new system was demonstrated by studying the effects of DNP, antimycin A, 
rotenone, and cyanide, whose mechanisms are well known 11-14, on fibroblast cell 
metabolism. The observed changes in CO2 production rates witnessed in our new system 
correspond well with the established mechanisms of action. The dissipation of proton 
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gradient by DNP was expected to yield an increase in CO2 production, whereas direct 
blocking of components in the electron chain transport was expected to yield decreases in 
CO2 production. The assay results provide quantitative measures for the degree of 
stimulation or inhibition of CO2 production by these chemicals. 
The sensitivity of the CO2 production rate assay was comparable to the growth 
test, where severe growth inhibition at minimum concentrations of antimycin A and 
rotenone first became visible at 48 hr. While DNP did not have a significant effect on 
growth at concentrations at its minimum tested, it did inhibit growth substantially at 
concentrations of 0.04 and higher (not shown). However, in all cases, the test was more 
sensitive than a cell death screen, as none of the chemicals caused cell death at 6 or 24 hr 
at the given concentration ranges that were tested in the CO2 production rate assay. For 
two chemicals, antimycin A and cyanide, we observed decreased viability at 
concentrations that were 25-30 times greater than those causing significant metabolic 
change within 6 hours. In summary, for the given fibroblast cell line and the chemicals 
tested, we have been able to precisely determine changes in CO2 production at 
concentrations which correspond to growth inhibition without cell death. Further work is 
needed to examine the correlation between metabolic changes and growth inhibition, as 
well as verify the use of shorter-term metabolic measures to predict longer-term 
physiological outcomes. 
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CHAPTER IV 
 
96-WELL PLATE ASSAY FOR SUBLETHAL METABOLIC ACTIVITY 
 
Abstract 
A 96-well plate assay has been devised for estimation of sublethal metabolic 
activity for compounds administered to in vitro cell cultures during 6 and 24 h exposures. 
This screen combines a resazurin reduction assay with lactate production and glucose 
consumption rate assays to assess effects of compounds on both culture viability and 
metabolic inhibition. In this paper, the assay is demonstrated by determining the extent to 
which five glycolysis inhibitors, namely phloretin, 2-DG, iodoacetate, fluoride, and 
oxamate, induce metabolic inhibition without cell death for in vitro fibroblast cell 
cultures. During 6-h exposures, iodoacetate was found to be the most potent inhibitor of 
glycolysis, while iodoacetate and phloretin were most cytolethal. 2-DG had the largest 
sublethal metabolic range, spanning just over two orders of magnitude in concentrations 
between its IC50’s for cytolethality and metabolic inhibition. This method provides a 
simple and inexpensive way to determine global metabolic and cytolethal effects of 
compounds for in vitro cell culture systems. It should be of use directly for large-scale 
screening and ranking of compounds during drug discovery and development, in 
conjunction with or following some more direct measure of therapeutic efficacy of a 
prospective drug candidate. Moreover, first-hand determination of the concentrations 
over which a compound has lethal, sublethal metabolic, or no such effects should serve as 
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a cost-effective and time-saving first step in a given research study, preceding more 
expensive, lengthy, and/or detailed in vitro methods. 
 
Introduction 
Current cytotoxicity assays, such as MTT, alamar blue, and neutral red, are 
widely used because they are cheap, easily quantified, and reproducible.1 However, all of 
these assays oversimplify the events that they measure, providing a binary outcome for 
multi-step, kinetic processes. The measured endpoints are generally late events of cell 
death and the information obtained is limited.2,3 Although tests for cytotoxicity will 
remain indispensable in modern drug development, there is a growing need for in vitro 
assays that assess toxicity of a compound more subtly at sublethal levels, which are 
recognized to be more indicative of mechanism and more predictive of toxicity.4 
Significant progress in technologies including genomics, proteomics, and metabonomics 
are providing the opportunity for measuring cellular responses at different levels of the 
biological hierarchy and regulation.5-7 These techniques have great potential for studying 
the mechanism of a compound’s action in a biochemical system and are certainly high-
content yielding methods, yet they are very expensive, labor intensive, and not high-
throughput. One major challenge for the application of these new techniques in 
toxicology is to determine appropriate doses at which to extract meaningful information.7 
Suitable dose selection is also required prior to the use of other more detailed in vitro 
testing for genotoxicity, induction of mutation, or programmed cell death. Cytotoxicity 
assays have played an important role in this regard, providing an upper bound for 
concentrations that induce cell death.4 Additional simple, global, sensitive, and 
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quantitative assays for measuring a morbidity state are needed to provide lower bounds in 
defining a sublethal concentration range. 
In this work, we implemented dual measurements of culture viability and 
metabolism in a 96-well plate assay which can bound the range of sublethal metabolic 
activity for a compound during an acute exposure (24 h or less) in vitro. In developing 
the assay, we tested a group of compounds that are reported to work as inhibitors of 
glycolysis, including phloretin, 2-DG, iodoacetate, fluoride, and oxamate. The sites of 
action for these inhibitors are listed in table 4.1.8-12 These inhibitors can be used as 
mechanistic tools for studying glycolysis, a prominent pathway in biochemistry, but 
whose regulation is also attracting attention with regard to its role in cell death13-16 and 
disease treatment.17-19 Of particular interest to us for subsequent metabolic control 
analysis experiments was the determination of concentrations of the aforementioned 
inhibitors that would be sufficient for inhibiting glycolysis in our fibroblast cell line yet 
without causing cell death. Of more general interest to the reader at large is the creation 
of a combined protocol for the assessment of cytolethality and metabolic inhibition of 
compounds on in vitro mammalian cell lines. This protocol provides dual dose response 
curves that bound a sublethal metabolic activity range. 
 
Materials and methods 
Cell culture and media 
Mouse fibroblast cells (ATCC CRL10225) used in this study were grown in 
“maintenance medium” consisting of DMEM (Mediatech, Herndon, VA, USA) 
supplemented with 10% FBS (Sigma, St. Louis, MO, USA), 10 U/mL penicillin-10 
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µg/mL streptomycin (Sigma), and 4 mM L-glutamine (Mediatech). The cells were 
maintained in 75 cm2 T-flasks (Corning, NY, USA) in an incubator (Model 3100 series, 
Forma Scientific, Marietta, OH, USA) controlled at 37 °C, 95% humidity, and 10% CO2. 
Every 4-6 days, cultures were trypsinized using a 0.25% solution of trypsin (Mediatech), 
counted by microscopy (Model BX60, Olympus, USA) using trypan blue (Mediatech) 
with a hemacytometer (Double Neubauer Counting Chamber Set, VWR International, 
Suwanee, GA, USA), and subcultured at an initial cell density of 2×105 cells/mL in 
maintenance medium. Medium used during a screen for testing compounds (test medium) 
is based on bicarbonate-free/glucose-free RPMI 1640 medium (Sigma), which is 
supplemented with 10 mM glucose, 10 mg/L insulin, 5 mg/L holotransferrin, 10 U/mL 
penicillin-10 µg/mL streptomycin, and 2000 mg/L sodium bicarbonate (all from Sigma). 
Serum is not used during a screen to avoid the need for deproteinization of samples prior 
to enzymatic assays.20 
Test compounds 
2-DG, sodium fluoride, sodium iodoacetate, sodium oxamate, and phloretin were 
all purchased from Sigma in powder form. Concentrated stocks of all chemicals were 
made in test medium. Stock concentrations were 1000 mM 2-DG, 100 mM sodium 
fluoride, 1 mM sodium iodoacetate, 500 mM sodium oxamate, and 1 mM phloretin. Prior 
to a screen, 5.0 mL volumes of test media with 11 different concentrations of a chemical 
were prepared by further dilution of concentrated stock into test medium. 
Enzymatic assays for glucose and lactate  
The glucose and lactate concentration in each well of a 96-well plate (NUNC, 
Nalge Nunc International, Denmark) used in a screen (“screening plate”) is measured by 
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enzymatic assays in separate 96-well plates, one for each assay (“assay plates”) (Nalge 
Nunc International). The assay recipes used allow determination of glucose in the range 
of 0 to 10 mM and lactate in the range of 0 to 3 mM. Both assays are based on those 
developed by Bergmeyer and Lowry.21,22 The glucose assay utilizes two reactions: in the 
first reaction, hexokinase catalyzes the conversion of glucose to G6P (Equation 4-1), and 
in the second reaction, G-6-PDH catalyzes the conversion of G6P to 6-phosphogluconate, 
with stoichiometric quantities of NADP+ converted to NADPH (Equation 4-2). The 
amount of NADPH produced is directly proportional to the glucose concentration 
contained in the sample and can be detected by absorbance.  
ADPPhosphateGATPeGlu Hexokinase +−− →+ 6cos    (4-1) 
NADPHconatePhosphogluNADPPhosphateG PDHG +− →+−− −−+ 66 6  (4-2) 
In the lactate assay, LDH catalyzes the reaction of lactate and NAD+ into pyruvate 
and NADH. The NADH produced is detected by the increased absorbance (Equation 4-
3). 
NADHPyruvateNADLactate LDH +→←+ +     (4-3) 
In this protocol, a serum-free, low-protein test medium and reformulated assay 
reagent recipes were used to reduce measurement noise and increase protocol 
efficiency.20 For the glucose assay, reagent A contains 15 mM ATP, 2.5 mM NADP+, 1 
mM MgCl2, 0.5 mM DTT, and 0.31 U/mL G-6-PDH in 25 mM Tris buffer solution with 
pH adjusted to 8.0 using NaOH; and reagent B is prepared by dissolving hexokinase in 
deionized water at a concentration of 6.67 U/mL (all from Sigma). For the lactate assay, 
reagent A contains 163.64 mM hydrazine, 64.21 mM glycine, and 10.55 mM NAD+ in 
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water with pH adjusted to 9.5 using NaOH, and reagent B is 1000 U/mL LDH solution 
(all from Sigma). 
To conduct an assay, each well of an assay plate is pre-filled with either 170 µL 
lactate assay reagent A or 165 µL glucose assay reagent A. Then, 20 µL samples from a 
screening plate are transferred to each well of an assay plate. The initial OD’s of each 
well on an assay plate are read at 340 nm using a µQuant Universal Microplate 
Spectrophotometer (Bio-Tek Instruments, Winooski, Vermont, USA). Then, 10 µL of 
lactate assay reagent B or 15 µL of glucose assay reagent B is added to each well of an 
assay plate. The lactate assay is incubated for 1 h and the glucose assay is incubated for 2 
h. Final OD’s are determined at 340 nm for both assays. All steps were performed at a 
stable room temperature of 21°C, and the assay incubation time was confirmed to be 
conservatively long enough to reach endpoints confirmed by unchanged absorbance in 
longer time. 
Resazurin reduction assay for relative culture viability 
The relative viability of test cultures during the three hours following the 
conclusion of either a 6 h or 24 h exposure is determined using a resazurin reduction 
assay. Resazurin reduction assay reagent was prepared by dissolving resazurin (Sigma) 
into PBS (Mediatech) at the concentration of 0.0105% (wt/vol).23 To conduct the assay, 
each well of a screening plate containing 100 µL of culture is provided with 10 µL of 
resazurin reduction assay reagent using a 12-channel manual pipettor (VWR 
International). After incubation for 3 hr in the incubator at 37°C, the fluorescence from 
each well is measured at a wavelength of 590 nm using an excitation wavelength of 560 
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nm and a sensitivity setting of 50 on a Bio-Tek FL600 plate reader (Bio-Tek 
Instruments). 
Protocol for 96-well plate assay for sublethal metabolic activity 
In preparation of an assay, five rows of a 96-well plate are seeded with 100 µL of 
a fibroblast cell culture using a manual single channel pipettor (VWR International) and 
incubated for 10 h to allow cells to attach. The other three rows are reserved as cell-free, 
left empty for the time being. The cell culture used to seed the plate is harvested from an 
80-90% confluent culture in a 75-cm2 T-flask, centrifuged at 200×g for 10 min (Model 
5677, Forma Scientific), and resuspended in maintenance medium at a density of 1.0×106 
cells/mL within a 50-ml centrifuge tube (Corning). This density corresponds to 
approximately 50% confluency in a 96-well at the time of seeding. 
The screen is initiated by removing the maintenance medium and washing all 
wells once with 200 µL of PBS pre-warmed to 37°C, and then filling wells of each of the 
12 columns with 100 µL of test media containing a specific concentration of a test 
compound. In this particular design, there are eleven distinct, nonzero concentrations 
tested plus one control, and each concentration is tested with five replicates with culture 
and three replicates cell-free. The well plate is next incubated for either 6 or 24 h at 37°C, 
95% humidity, and 10% CO2. At the end of the exposure period, 20 µL samples for 
metabolite assays are taken and immediately transferred to assay plates, which are pre-
filled with reagents needed for the enzymatic assays. In the case of a 6-h exposure period, 
one sample is taken from each well for a lactate assay. In the case of a 24-h exposure, two 
samples are taken from each well for a lactate and glucose assay, diluting the lactate 
samples 6-fold before assaying them. Next, the remaining medium in each well is 
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removed, all wells are washed with 200 µL of pre-warmed PBS, 100 µL of fresh 
compound-free test medium is added to each well of the screening plate, 10 µL of 
resazurin reagent is added to each well, and fluorescence is read at the end of incubation 
at 37°C for 3 h. All liquid handling steps were accomplished using a manual 12-channel 
pipettor (VWR International). 
A variation in the protocol for the resazurin assay was also tested during 
development to probe the effect of having compounds present during the assay and 
investigate possible detachment of cells during the washing step. Here, wells were re-
filled to 100 µL volumes by addition of 20 µL (for 6 h exposures) or 40 µL (for 24 h 
exposures) of compound-containing medium. Comparison of results obtained by each 
procedure revealed a significant yet small difference (about 1%) in results (not shown), 
signifying that cell detachment during medium exchange and washing was not a problem 
and that the presence or absence of the compound did not affect the resazurin reduction 
assay. Additionally, comparison of absolute fluorescences from resazurin reduction 
assays for control culture wells during 6-9 hr and 24-27 hr indicated that growth rate was 
negligible under test conditions. 
Calculation of lactate production, glucose uptake, and resazurin reduction relative to 
control cultures 
 
The change in absorbance of NADH (for lactate) or NADPH (for glucose) during 
an enzymatic assay is linearly proportional to the concentration of the respective 
metabolite in a sample. The amount of lactate produced or glucose consumed by the cells 
during an exposure period is calculated as the difference between changes in absorbance 
for culture samples and cell-free samples, and normalized to the difference exhibited by 
the control cultures. Equation 4-4 provides an expression for lactate production relative to 
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the control; a similar equation is used for glucose consumption relative to the control, 
glucose uptake  (% of control), not shown. 
Lactate Production (% of control) 100
)(
)( ×∆−∆
∆−∆=
−
−
controlfreecellcell
testfreecellcell
ODOD
ODOD
 (4-4) 
Typical values for changes in absorbance for samples from culture wells and cell-
free wells ranged from 0.04-1.00 and 0.02-0.03, respectively, for lactate during 6 h 
exposure, and 0.8-2.8 and 2.8-2.9, respectively, for glucose during 24 h exposure. 
For the resazurin reduction assay, only final fluorescence is measured. The 
resazurin reduction (RR) relative to the control is calculated as shown in equation 4-5.  
RR (% of control) 100
)(
)( ×−
−=
−
−
controlfreecellcell
testfreecellcell
ceFluorescenceFluorescen
ceFluorescenceFluorescen
 (4-5) 
Typical values for fluorescence for culture wells and cell-free wells ranged from 
900-36,000 and 875-925, respectively. 
Determination of IC50 for metabolism, IC50 for resazurin reduction, and the sublethal 
metabolic activity range 
 
The median inhibitory concentration (IC50) values for glucose and lactate 
metabolism (IC50GLC, IC50LAC, or IC50MET in general) and for resazurin reduction (IC50RR) 
were obtained from semi-logarithmic dose-response curves (Figure 4-1). Either a 
Sigmoidal function (Equation 4-6) or a dual exponential function (Equation 4-7) was 
used to fit each of the curves. Curve fitting was accomplished using the “curve fitting 
toolbox” in Matlab (Mathworks, Inc), with choice of fit based on the goodness of 
regression coefficient (R2). IC50 values were back calculated from the fitted functions. 
The sublethal metabolic activity range was calculated as the log of the ratio of IC50RR 
over IC50MET (Equation 4-8). 
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Statistical tests 
Differences between results obtained from 6-h and 24-h exposures for IC50LAC, 
IC50RR, and sublethal metabolic activity range for individual compounds were tested for 
significance using two-sample t-tests. These same differences between 6-h and 24-h 
results were also tested for significance by taking data for all the compounds together (in 
conglomeration) and using paired comparison t-tests, with data paired by compound. For 
such conglomerate analyses, the logarithms of the ratio of paired IC50’s were compared to 
zero, while the differences between pairs of data for sublethal metabolic activity were 
compared to zero. Differences between IC50LAC and IC50GLC for individual compounds 
from 24-h exposures were tested for significance also using paired comparison t-tests, 
with data paired by well plate (since both values were determined from same well plate). 
This same difference was also tested for significance taking the data in conglomeration, 
still using a paired comparison t-test, but comparing the logarithm of the ratio of the 
paired quantities to zero. Differences between resazurin reduction relative to control 
measured in the presence and absence of compound for all compounds at 6h and 24 hr 
were compared using paired comparison t-test, with data paired by each concentration. 
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Results 
Determination of sublethal metabolic activity for fibroblast cultures treated with 
glycolysis inhibitors 
 
The degree to which fibroblast glycolysis could be inhibited without causing cell 
death was explored using five inhibitors of glycolysis, namely phloretin, 2-DG, 
iodoacetate, fluoride, and oxamate. Results from a 6-h exposure provide two dose 
response curves for each of the five inhibitors, each curve consisting of 11 points 
normalized to controls (Figure 4-1). The data for lactate production correspond to the 
average rate of lactate production over the 6-h period. The data for resazurin reduction 
are taken as an indication of the average number of viable cells during the three hours 
following the exposure. Dose response data sets that exhibited a gradual transition over 
the concentration range tested (all of the lactate production data and the resazurin 
reduction data for iodoacetate) were fitted using dual exponential functions. Dose 
response data sets that exhibited a sharp transition (all the resazurin data except that for 
iodoacetate) were fitted using Sigmoidal functions. The data demonstrate that lactate 
production can be notably inhibited at concentrations lower than those affecting resazurin 
reduction with the discrepancy depending on the type of compound. This range in which 
central metabolism can be significantly inhibited yet without effect on resazurin 
reduction is interpreted as a range of sublethal metabolic activity for a given compound. 
In this study, sublethal metabolic activity was evident for concentrations that were one or 
more orders of magnitude lower than those causing cell death. 
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Figure 4.1. Resazurin reduction and lactate production for fibroblast cell cultures 
exposed for 6 h to different concentrations of phloretin (A), 2-DG (B), iodoacetate (C), 
fluoride (D), and oxamate (E).  (g) and (♦) denote measured lactate production and 
resazurin reduction, respectively, each as percentages of control cultures. Measured 
points shown in the figure are averages and standard deviations of five wells from a 
single 96-well plate. Solid and dashed lines correspond to fitted functions for lactate 
production and resazurin reduction, respectively. Each experiment was replicated three 
times (Only one replicate for each compound is shown). 
 
 
 
The cytolethal and metabolic inhibition effects of each compound during a 6-h 
exposure are quantitatively compared based on calculated IC50’s for resazurin reduction 
and lactate production, respectively (Table 4-1). The data for IC50RR indicates that 
phloretin and iodoacetate were the most cytolethal, followed by fluoride, oxamate, and 2-
DG, in order of decreasing cytolethality. Meanwhile, the data for IC50LAC show that 
iodoacetate was the most potent metabolic inhibitor, followed by phloretin, fluoride and 
2-DG, and oxamate, in order of decreasing potency. The orders of rankings based on 
cytolethality and potency for metabolic inhibition differ. However, the IC50LAC’s were 
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less than corresponding IC50RR’s for each of the five compounds. The range to which a 
compound exerts sublethal metabolic activity is quantified as the logarithm of the ratio of 
IC50RR to IC50LAC. This quantity is the order of magnitude, in a base-10 system, between 
the IC50’s. As shown in table 4-1, sublethal ranges spanned orders of magnitude as wide 
as 2.3 and as little as 0.3. 2-DG exhibited the greatest span, followed by iodoacetate, 
oxamate, fluoride, and phloretin, in order of decreasing range for sublethal metabolic 
activity. 
 
Table 4-1. IC50 values for lactate production and resazurin reduction and sublethal 
metabolic activity range for five compounds tested on fibroblast cultures during 6-h 
exposures. The inhibitors are listed in the order of the steps of glycolysis, along with their 
sties of action. Data shown in the table are average and standard deviation of three 
independent replicates of the 96-well plate assay. 
 
IC50 (mM) 
Chemical Target Lactate Production Resazurin Reduction 
Sublethal 
Metabolic 
Activity Range 
Phloretin GLUT1 0.05 ± 0.01 0.0828 ± 0.0001 0.3 ± 0.1 
2-Deoxyglucose Hexokinase 4.1 ± 0.5 756 ± 79 2.3 ± 0.1 
Sodium Iodoacetate GAPDH 0.0049 ± 0.0003 0.12 ± 0.01 1.41 ± 0.04 
Sodium Fluoride Enolase 4.7 ± 1.4 18.2 ± 2.3 0.6 ± 0.2 
Sodium Oxamate LDH 14.2 ± 1.2 86 ± 16 1.117 ± 0.004 
 
 
 
Comparison of sublethal metabolic activity during 6-h and 24-h exposures 
The extent to which the results of a screen are dependent on exposure time was 
explored by comparing results obtained during 24 h versus 6 h exposures (Figure 4-2). 
The only substantial effect was for the cytolethality of iodoacetate, as evidenced in an 
IC50RR that is reduced by an order of magnitude. This makes iodoacetate the most 
cytolethal compound based on 24-h results and places it as fourth largest in regard to its 
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sublethal metabolic activity range, whereas the ranking based on metabolic inhibition 
remained unchanged. 
After exclusion of iodoacetate, analyses of data for all compounds in 
conglomeration revealed that IC50 values for resazurin reduction were barely statistically 
significant (p = 0.0495), yet with 4 of 5 compounds exhibiting statistical significance 
individually. That IC50RR’s determined over 24 h are less than those determined over 6 h 
conforms with an understanding that cell death may exhibit varying kinetics and may not 
be complete within 6 h. Differences in IC50LAC values from 6 h and 24 h assays were not 
statistically significant in conglomeration (p = 0.1800), though 2 of 5 compounds were 
statistically significant individually. Notably, IC50LAC’s for iodoacetate were not 
observably different. The combined effects of changes in IC50’s for lactate production 
and resazurin reduction yielded ranges for sublethal metabolic activity from 24-h 
exposure data that were generally slightly lower than those from 6-h exposure data. The 
differences analyzed in conglomeration were not statistically significant (p = 0.0739), 
though 2 of 5 compounds were statistically significant individually. 
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Figure 4.2. Comparison of IC50’s and sublethal ranges determined during 6-h versus 24-h 
exposures. Black and white bar represent 6- and 24-h results, respectively, for IC50 for 
resazurin reduction (A), IC50 for lactate production (B), and sublethal metabolic activity 
range (C). Results shown are averages and standard deviations of three independently 
conducted replicate screens. Mean differences of data taken in conglomeration for each 
group, excluding iodoacetate data in A and C, were -0.24±0.15 (Fig. A: n =4, p = 
0.0495), -0.09 ± 0.13 (Fig. B: n = 4, p = 0.1800), and –0.14±0.10 (Fig. C: n =5, p = 
0.0739). Results for individual compounds that are statistically significant at the 95% 
confidence level are denoted with an asterisk. 
 
 
 
Comparison of sublethal metabolic activity based on glucose consumption versus 
lactate production 
 
During assay development, we also measured glucose consumption during 24-h 
exposures for all compounds except for 2-DG (Figure 4-3). Samples for glucose assay 
from cultures exposed to 2-DG were processed, but, as was evident from cell-free 
controls, 2-DG interfered with the hexokinase-based enzymatic assay (data not shown). A 
conglomerate analysis of paired differences reveals that IC50LAC values were statistically 
less than those for IC50GLC, but none of the results for individual compounds were 
statistically significant. The small differences between IC50’s for metabolic inhibition 
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observed in this study suggest a possibility to use one or the other for estimation of 
sublethal metabolic activity range, as needed for a particular study. 
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Figure 4.3. Comparison of 24-hr IC50 values based on lactate production and glucose 
consumption. Black and white bars represent IC50 values for lactate production and 
glucose consumption, respectively. Results shown are averages and standard deviations 
of three independently conducted replicate screens. The mean difference for data taken 
in conglomeration was –0.16±0.22 (n =12, p = 0.0314). None of the differences for 
individual compounds were statistically significant at the 95% confidence level. 
 
 
 
Discussion 
This work provides a proof of a concept regarding a prospective new dimension 
to mammalian cell-based assays, namely that of a range over which compounds can have 
noticeable effects on glucose and lactate metabolism, yet without causing cell death as 
defined by resazurin reduction during acute exposures. The interpretation of this range as 
a sublethal metabolic range involves an assumption that net resazurin reduction indicates 
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number of viable cells, which in turn depends on the assumption that viable cells have a 
constant cell-specific resazurin reduction rate. The mechanism of resazurin reduction is 
not very clear, but the use of its activity as an indicator for viability has been widely 
practiced due to its easy performance and low cost.24,25 In chapter III, the assumption of 
using it as an indicator of viability was found to be acceptable for the fibroblast cell line 
during exposures with antimycin A and potassium cyanide upon comparison of viability 
results obtained with MTT, resazurin reduction, and trypan blue assays.26 
Still, since the rate of resazurin reduction, like any other cellular biochemical 
reaction, may vary depending on substrate and product metabolite levels and as well as 
enzyme levels and effective activities, some degree of caution should be exercised in 
interpreting the results. The present results differentiate the effects of compounds on 
resazurin reduction activity from those on glucose and lactate metabolism. Under the 
assumption that reduced resazurin reduction indicates death of cells, the two dose 
response curves separate the entire spectrum of compound concentrations into three 
zones. The resazurin reduction data bounds the upper range where death occurs while the 
metabolic assay separates a sublethal metabolic activity range with that of the “sub-
metabolic” range. 
Prospective applications for this screen are conceivably numerous. More intricate 
experiments of in vitro cellular studies involving more expensive or elaborate techniques, 
such as 2-D gels or gene chips or using radio-labeled substrates, ought to benefit 
tremendously from first-hand, quantitative, relatively inexpensive dose-response data 
obtained in a day’s time. For instance, the assay may be used to compare in vitro cellular 
environments (i.e. design of test media or serum-free formulations in general), to study 
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chemical toxins, to screen candidate drugs, and/or to select clones or differentiate 
between cell types, broadly spanning fields of biotechnology through toxicology and 
pharmacology to medicine. More generally, this work demonstrates the strategy for 
parallel measurements of a functional criterion (here, metabolism) with one for culture 
viability. Obtaining dose information for potency and lethality, and hence relative safety 
in vitro, both from the same screen should be of value for large-scale screening of 
compounds during early stages of drug discovery and development. Ideally, improvement 
of preliminary methods for screening compounds, medium, and cells for in vitro studies 
should help increase the efficiency and productivity of subsequent steps in a research 
project, lowering costs in the end. 
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CHAPTER V 
 
METHOD FOR CHARACTERIZING CHANGES IN METABOLIC STATE OF 
MAMMALIAN CELLS 
 
 
Abstract 
A 24-well plate assay for measuring metabolic rates of glucose, lactate, and CO2 
in conjunction with a carbon balance model are presented herein for characterizing 
changes in the metabolic state of fibroblast cells treated with chemicals at sublethal 
levels. The assay and method are demonstrated by testing four well characterized 
metabolic agents, oxamate, fluoride, antimycin A, and DNP, which act on different sites 
in glycolysis, the electron transport chain, and mitochondria. Depending on the sites of 
action, different patterns of increases and decreases of the three metabolic rates were 
observed. Moreover, higher sensitivity of one metabolic rate was associated with the 
closeness of the pathway to the action site of the compound. Furthermore, in response to 
four chemicals at different doses, cells responded by altering metabolic state in three 
different ways: uniform change of metabolic rates, metabolic shift, and metabolic switch. 
 
Introduction 
Toxicity testing with cell cultures has often focused on late, irreversible cell death 
events as endpoints.1,2 These approaches appear too simplistic and the mechanistic 
information obtained is limited.3,4 Demonstrating the lack of toxicity may also require 
more subtle analyses of molecular events and precise metabolic regulation preceding cell 
death.3,5,6 The insurgence of high throughput genomics and proteomics allows 
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multidimensional readouts of molecular events at unprecedented levels of details.7 The 
information obtained by them is mechanism indicative and toxicity predictive.7-9 
However, the methods are expensive and labor intensive. They were generally applied at 
only a single dose but a compound acts as a function of doses.10 Moreover, functional 
information can not be inferred from gene and protein expressions without including the 
metabolic status of the whole organism. 6,7,9,11,12 In some cases, toxic effects for some 
chemicals may not involve gene and protein expressions.12,13 Metabolic status should be 
included to augment and complement the information provided by measuring genetic and 
proteomic responses.6,9,11,12 
Metabolic rates define the minimum information needed for describing 
metabolism and cell physiology.14 Traditional methods have often used large volumes of 
cultivation systems (such as flasks and reactors) for measuring metabolic rates.15 Those 
approaches have often been used in bioprocess and bioengineering research for studies of 
metabolism to improve cellular properties.14,16,17 However, applications of these methods 
for screening purposes are hindered due to their low throughput, high cost, and lengthy 
time-consumption.15 Development of high throughput methods for measuring metabolic 
rates is necessary for applications in toxicity testing and pharmaceutical research, but also 
to satisfy the requirement in other areas like functional genomics and metabolic 
engineering.18,19 Measuring metabolic rates in micro-scaled well-plate systems offers an 
attractive format, which allows parallel cultivation of independent, large numbers of 
cultures and has the potential to be automated.20 Reported metabolic rate assays 
performed in well plate systems include measurement of acidification rate, glucose, 
lactate, oxygen, and CO2.15,21-25 However, most of these assays measure only single or at 
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most two metabolites, whereas a multidimensional approach for simultaneous 
measurement of multiple metabolites would offer a more comprehensive understanding 
of changes in cellular metabolism in response to various stresses.26 
In this work, I developed a high throughput, multi-parallel method for measuring 
metabolic rates of glucose, lactate, and CO2 in 24-well plates to characterize the changes 
in central carbon metabolism of mammalian cells. In developing the method, four 
metabolic agents, oxamate, fluoride, antimycin A, and DNP, were tested at sublethal 
levels to verify the assay and obtain different metabolic statuses. The sites of action for 
these agents are listed in table 1.27-31 The measured rates were used directly, as well as in 
conjunction with a carbon balance model to characterize the changes in metabolic state of 
fibroblast cells. Applications of the method include preclinical toxicity testing, screening 
novel drug candidate, cell line screening, and medium optimization. 
 
Materials and methods 
Cell culture and media 
The cell line used is a mouse fibroblast cell line obtained from ATCC (CRL-
10255). During routine maintenance, cultures are grown in a 75 cm2 T-flask (Corning, 
NY) in an incubator (Model 3100 series; Forma Scientific, Marietta, OH, USA) 
controlled at 37 °C, 95% humidity, and 10% CO2. The maintenance medium consists of 
Dulbecco’s Modification of Eagle’s medium (DMEM) (Mediatech, Herndon, VA, USA), 
which is supplemented with 10% fetal bovine serum (FBS) (Sigma, St. Louis, MO, 
USA), 10 U/mL penicillin-10 µg/mL streptomycin (Sigma), and 4 mM L-glutamine 
(Mediatech). Subculturing is conducted every 4-6 days by removing the medium, 
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detaching the cells with 0.25% trypsin-0.1% EDTA (Mediatech), and diluting the culture 
with fresh medium to a cell density of 2×105 cells/mL. At least 3 passages after the initial 
thaw are performed before using the cell culture for screening experiments. 
Two different media are used during a screen, one is for attaching cells to the 
screen well plate, and the other is for measuring concentration changes of metabolites 
during chemical exposure. The media components are identical to the “pretest” medium 
and “test” medium for CO2 production rate assay as described in chapter III. Medium 
used during cell attachment prior to the start of screen (“pretest” medium) is based on 
bicarbonate-free/glucose-free RPMI 1640 medium (Sigma), which is supplemented with 
10% FBS, 25 mM D-glucose, 10 U/mL penicillin-10 µg/mL streptomycin (Sigma), and 
buffered with 50 mM HEPES (Mediatech). Medium used during the chemical exposure 
(“test” medium) is the same as the pretest medium, with the exceptions of substituting 10 
mg/L insulin and 5 mg/L holotransferrin for serum, reducing glucose to 4.0 mM and 
increasing phenol red to 30.0 mg/mL (Sigma). The designs of the pretest medium and test 
medium are for precise measurement of metabolite concentration change in a screen.15,25 
Sodium bicarbonate is not used as buffer since it will confound the lesser amount of CO2 
produced by cells. Instead, a higher concentration of HEPES is used to minimize the pH 
change, which allows more liquid phase CO2 to accumulate in a stable bicarbonate form. 
Serum is used in the pretest medium to deactivate the trypsin for cell attachment, but not 
in the test medium to avoid the need for deproteinization of samples prior to enzymatic 
assays.  The increased phenol red concentration in the test medium is for spectroscopic 
pH measurement.  The decreased glucose concentration in the test medium is for 
increasing the precision of the glucose assay. 
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Test chemicals 
Sodium oxamate, sodium fluoride, antimycin A, and 2,4-dinitrophenol (DNP) 
were all purchased from Sigma. Concentrated stocks of oxamate and fluoride were made 
in culture water, whereas a concentrated stock of DNP was made in DMSO and a 
concentrated stock of antimycin A was made in ethanol, respectively. Prior to a screen, 
test media with five different concentrations of a chemical plus control were prepared by 
further dilution of concentrated stocks into test medium. The control and the five test 
media are then given necessary amounts of pure solvent such that the final concentration 
of solvent in every medium was equal at 1% (v/v). The solvent impact on culture 
metabolism was found to be negligible by comparing metabolic rates of control cultures 
added with 1% of water, ethanol, and DMSO. 
Metabolic rate screening 
Metabolic rate screening for measuring changes in extracellular glucose, lactate, 
and CO2 of fibroblast cell cultures is carried out in 24-well plates (BD Biosciences, San 
Jose, CA, USA). To increase the efficiency and reduce the cost, prior to a 24-well plate 
screen, the sublethal concentration range for each chemical is determined in a 96-well 
plate screen during 6- and 24-h exposures (described in Chapter 4).24 From such tests, 
concentration ranges in which there were changes in metabolism but no cell death were 
determined for each chemical (Table 5.1). From such a narrowed range, concentration 
points for a chemical are selected for further testing in this 24-well plate screen. 
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Table 5.1. Sublethal concentration range for each compound. Concentration points tested 
for each chemical in 24-well plate screening are selected from within a sublethal 
concentration range. The range of sublethal activity for each compound was determined 
by dual measurements of culture viability (using alamar blue assay) and metabolism 
(using glucose and lactate assay) during 6 hr and 24 hr exposure in a 96-well plate assay. 
The lower bound is defined by the minimum observed concentration required to elicit 
changes in metabolism. The upper bound is defined as the maximum concentration which 
does not cause significant cell death (viability greater than 85% of control confirmed by 
alamar blue assay).  
 
Sublethal Range (mM) Chemical Target Test Range (mM) 6-h 24-h 
Oxamate LDH 6 − 50 2.5 − 75 5 − 50 
Fluoride Enolase 1 − 3 0.1 − 10 0.1 − 5 
Antimycin A Complex III 2.5e-6 − 1e-4 2.5e-6 − 0.01 2.5e-6 − 0.01
DNP Mitochondria 0.003 − 0.05 2.5e-3 − 1.0 2.5e-3 − 1.0 
 
 
 
A complete 24-well plate screen consists of three major steps: attaching cells into 
a 24-well plate, treating cells with chemical, and analyzing concentration changes of 
metabolites. The procedures are similar to conducting a CO2 production rate assay as 
described in chapter III.25 In preparation of a 24-well plate screen, each well in three rows 
of a 24-well plate is seeded with 500 µL of a fibroblast cell culture, and the remaining 
one row is reserved as cell-free. The cell culture used to seed the plate is harvested from a 
80-90% confluent culture in a 75 cm2 T-flask, centrifuged at 200 g for 10 min (Model 
5677, Forma Scientific) and resuspended in pretest medium at a cell density of 1.5×106 
cells/mL in a 50-mL centrifuge tube (Corning). The cell seeding is accomplished using a 
manual single pipettor. Vortexing of the cell culture is done before seeding to each well 
to minimize the seeding variation. The well plate is then incubated in an oven (VWR 
International, Suwanee, GA, USA) with ambient levels of CO2 at 37 °C for 10 hr to allow 
cell attachment. Next, the pretest medium is removed; all wells are washed with pre-
 98
warmed phosphate-buffered saline (PBS) (Mediatech) at 37 °C, and 500 µL of test media 
containing specific compound concentrations are added to each well, including the cell-
free well. Each well of the plate is then sealed by manual application of custom made 
plugs and incubated in the oven for 6 hr at 37 °C. At the end of the incubation period, 
absorbencies at 562 and 720 nm are read first for pH measurement, and each well is then 
unsealed and sampled immediately for an enzymatic assay of dissolved carbon dioxide 
and bicarbonate. Finally, samples are taken for enzymatic assays for glucose and lactate, 
and cell number and viability are determined for one well of each column (of each 
chemical concentration) by hemocytometer (Double Neubauer Counting Chamber Set; 
VWR International) with trypan blue staining (Mediatech). Each experiment was 
performed twice to provide a replicate data set. 
During cell attachment and incubation, an oven with ambient CO2 (300 ppm) 
instead of a CO2 incubator is used to minimize the interference of environmental CO2 on 
measurement of CO2 produced by cells. During chemical exposure, airtight well sealing 
with reduced headspace by the plugs prevents release of CO2 and allows accumulation of 
more dissolved carbon dioxide in equilibrium with bicarbonate in the liquid phase, from 
which samples will be taken for the CO2 enzymatic assay. The sealing plugs are made of 
translucent polycarbonate. Their dimensions and design are described in the chapter III.25 
The translucency of the plug allows the spectrophotometric pH measurement, which is 
required for calculation of CO2 in the headspace.  
Metabolite assays  
Determination of CO2 production by cells consists of two measurements: medium 
pH and total liquid phase CO2 (dissolved CO2 and −3HCO ). The principle, recipe, and 
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detailed procedures of the methods are described in chapter III.25,32,33 Briefly, the pH is 
determined by measuring absorbance of the pH indicator, phenol red, at a wavelength of 
562 nm. To correct for variations due to plug clarity, condensation, and well plate 
background, an absorbance at 720 nm is taken and subtracted. The total liquid phase CO2 
is determined by enzymatic assay in a separate 96-well plate. Triplicate measurements for 
each well of a 24-well plate were conducted.  
The glucose and lactate concentrations are also measured by enzymatic assays in 
separate 96-well plates. Both assays are based on those developed by Bergmeyer and 
Lowry 34,35 and reformulated to new protocols which allow determination of glucose in 
the range of 0-5 mM and lactate in the range of 0-3 mM.15 Deproteinization steps are 
omitted to increase the efficiency and precision of the assays. Triplicate measurements 
for each metabolite in each well of a 24-well plate are performed.  
Absorbance readings for pH measurement are performed on a Bio-Tek FL600 
plate reader (Bio-Tek Instruments, Winooski, Vermont, USA) with the temperature 
controlled at 37°C, and absorbance readings for all enzymatic assays are performed on a 
µQuant Universal Microplate Spectrophotometer (Bio-Tek Instruments) at room 
temperature. 
Calculation of concentration differences  
The carbon dioxide exists in the liquid phase and gas phase in a sealed system. 
With the measured pH and total liquid phase CO2, the total CO2 present in a well can be 
calculated based on dissociation equilibrium and Henry’s law, and expressed in 
concentration form based on culture volume as 
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with a dissociation constant K of 7.28×10-7 mol/L and a Henry’s law constant of 4.2×106 
Pa⋅L/mol taken from the literature.36 The volumes of cell culture and headspace are 0.5 
and 1.1 mL, respectively. The value of ideal gas constant R used is 8.31 x103 Pa.L/mol/K. 
With the measured metabolite concentrations at the final time point, concentration change 
of a metabolite during a 6-hr incubation for each well containing cell cultures can be 
calculated as the difference between the culture samples and cell-free samples (Equation 
5-2). 
)()( ,, ffreecellmetfcultmetmet tCtCC −−=∆      (5-2) 
Metabolic network model and consistency with sets of measured rates 
To characterize the metabolic state of fibroblast cells under chemical treatment, a 
simplified, 6-flux metabolic network (Figure 1 and Table 2) is devised and its consistency 
checked with the three measured metabolic rates at different conditions. The network 
represents two major central carbon metabolic pathways for energy production: 
glycolysis and the TCA cycle; and consists of three components: the conversion of 
glucose to pyruvate, the anaerobic conversion of pyruvate into lactate, and aerobic 
conversion of pyruvate to CO2. The creation of the network follows the principle that 
only feasible and observable biochemical reactions should be included in an assumed 
network for valuable information.14 Amino acids and other biosynthesis pathways are 
excluded. The unobservable sequence of reactions between critical metabolites in 
glycolysis and the TCA cycle are lumped as overall fluxes: 1v , 11v , and 20v . 
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Figure 5.1. Metabolic networks. The network represents glycolysis and TCA cycle. The 
intracellular fluxes are denoted by iv , and the measured metabolic rates are denoted with 
iq . The species used in material balance equations to derive the constraint equation are 
underlined. 
 
 
  
Table 2. Reactions used for the metabolic networks. 
 
1 Glc+2NAD++2ADP+ 2Pi → 2 Pyr + 2 NADH ++ 2 ATP + 2 H20 + 2 H+ 
11 Pyr+NADH+H+ → Lac+NAD+ 
20 Pyr+4NAD++FAD+ADP+3H2O+Pi → 3CO2+4NADH+FADH2+ATP+4H+ 
 
 
The method for checking consistency between the simplified network and the 
three measured rates is developed based on the method described by Stephanopoulos 37, 
but modified for statistical comparison of the changes in metabolic state of cells. The 
generation of constraint equations for consistency testing starts with the pseudo-inverse 
solution method, which assumes that the pathway intermediates are at a pseudo-steady 
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state. Under this assumption, the three measured rates ( glcq , lacq  and 2COq ) and the three 
intracellular fluxes ( 1v , 11v , and 20v ) are related by 4 material balances around the 
intermediates (glucose, lactate, CO2 and pyruvate), as shown in matrix form: 
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The numbers in the matrix are stoichiometric coefficients for the 4 intermediates 
in the transport and reaction equations (Table 2, transport equations not listed), which are 
placed into the matrix with rows for each metabolite balanced and columns for each 
rate/flux. As 6 fluxes are related by 4 balances, measuring three metabolic rates yields an 
overdetermined system of equations, with one redundant measurement. The redundant 
information can be used to check the consistency between the metabolic reaction network 
and the measured rate data set. To describe the various steps for derivation of the 
redundant equation, the system of linear equations in matrix form is simply expressed as 
0=vGT          (5-3) 
where TG  represents the transposed stoichiometric matrix (as shown above), and v  is the 
vector which collects the measured rates and intracellular fluxes. By collecting the 
measured rates in a new vector, mv , and the intracellular fluxes in another vector, cv , 
TG can be partitioned and equation 5-3 can be rewritten as: 
0=+= cTcmTmT vGvGvG        (5-4) 
From equation 5-4, cv  can be calculated as 
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By inserting cv back to equation 5-4, the redundant matrix R can be obtained: 
0))(( # =−= mTmTcTcTmm vGGGGRv       (5-7) 
If R is not of full rank, it can be reduced down to just the number of rows that equal its 
rank, rR , and the equation 5-7 is written as:  
0=mrvR          (5-8) 
in which, the rows contained in the matrix rR  represent independent relationships that 
should be satisfied by the measurements. In fact, the product of mr vR is rarely equal to 0 
due to errors on measurements and/or errors in the model. As a consequence of such 
errors, it is better to express equation as  
mr vR=ε           (5-9) 
where ε  is the vector of residuals. For the simplified network of this work, 
the mr vR yields one redundant equation: 
26
1
2
1
COlacglc qqq ++=ε        (5-10) 
which describes the carbon material balance (carbons entering a cell as glucose should be 
equal to the carbons exiting a cell as lactate and CO2).  
The measured data from a 24-well plate screen are concentration changes of 
glucose, lactate, and CO2 (Table 5.3). Average metabolic rates for a culture in a single 
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well can be calculated as the concentration difference for a metabolite divided by an 
estimate of the average viable cell density during the incubation and the time. 
tn
Cq
v
∆=          (5-11) 
However, since the cell number and incubation time in the denominator are the 
same for all three rates in one well, it is more convenient to do the consistency test on the 
metabolite concentration differences directly. The numbers of cells and the incubation 
time can still affect the value of ε  by altering the magnitude of the observed changes. 
Thus, the variations due to cell number differences between wells are minimized by 
normalizing ε  to glcq  for each well. The normalized ε  is calculated as 
glc
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The magnitude of normε  indicates the extent of deviation of one measured data set 
from the simplified network. If the simplified network matches the measured data sets 
perfectly, normε  is equal to 0, while a positive value of normε  corresponds to carbons from 
glucose being in excess of those captured in lactate and CO2, and vice versa for negative 
normε . 
With a data set from only a single replicate, it is not possible to know if the 
inconsistency between the network and the measured rates is due to measurement errors 
or the incorrect network when normε  is nonzero. However, with multiple replicates 
provided by 24-well plate experiments, reliable judgment can be made by statistical tests. 
The measurement errors of the metabolites are confirmed to be random and normally 
distributed. The normalized residuals, normε , the sum of measured concentration 
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differences, is therefore also normally distributed, which allows statistical comparisons 
using a t-test. The judgment whether the difference between an average of normalized 
residuals for a given condition and 0 is significant or not is based on a one-sample t-test: 
ErrorStd
t norm
0
1
−= ε         (5-13) 
The judgment whether the difference between the averages of normalized 
residuals at different conditions is significant or not is based on a two-sample t-test: 
ErrorStd
t normnorm 212
εε −=         (5-14) 
Comparison of averages of 6 replicates at one condition to zero has the degree of 
freedom equal to 5, while comparison of average of 6 replicates at one condition to the 
other condition has the degree of freedom equal to 10. From the t distribution table, t 
value greater than 2.571 for 1t and 2.228 for 2t  indicate the differences are significant at a 
95%confidence level. Significant differences between an average of the normalized 
residuals and zero mean the network is not consistent with the measured data sets for a 
given condition. Significant differences between different conditions mean a metabolic 
switch has occurred, meaning the carbon balance is no longer upheld to the same extent 
as a control culture.  
Statistical tests 
Differences between control and test cultures for concentration differences of 
metabolites, ratio of metabolic rates are compared using two-sample t-tests. During 
comparison of concentration differences of metabolites, concentration differences of a 
metabolite of all wells in a well plate are normalized to the first well to minimize the 
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effect of cell number variation between well plates. All statistical treatments are 
accomplished in Microsoft Excel. 
 
Results 
Determination of concentration changes of glucose, lactate, and CO2  
The assay was demonstrated by measuring metabolite concentration changes of 
fibroblast cells treated over a 6-hr incubation period with oxamate, fluoride, antimycin A, 
and DNP at different levels. The concentrations tested for each chemical were selected 
from a sublethal concentration range determined by a 96-well plate screen for 6- and 24-
hr exposure levels. No occurrence of cell death at the concentrations tested was further 
confirmed using trypan blue exclusion method immediately at the end of the 6-hr 
incubation period for each screening experiment. Applying the newly developed 24-well 
plate assay, 18 data sets of concentration differences for glucose, lactate, and CO2 over a 
6-hr period were obtained in parallel from each well (Table 5.3, 6 wells for cell-free). In 
one well plate, a chemical can be tested at 5 distinct, nonzero concentrations with three 
replicates using our design, this being one possible layout. The measurement errors for 
glucose, lactate, and CO2 assays are less than 0.12, 0.05, and 0.05 mM, respectively. 
Small variations are present between wells at a specific condition, which might be due to 
cell seeding variation. 
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Table 5.3. Change in metabolite concentration, ratio, and residual. Concentration 
differences of glucose, lactate, and CO2 are measured values. Negative values indicate 
metabolite consumption, whereas positive values indicate metabolite production. The 
measured data sets are used to calculate the ratio and the normalized residual for each 
well. 
  
Oxamate 
(mM) 
∆Glc 
(mM) 
∆Lac 
(mM) 
∆CO2 
(mM) ∆Lac/∆Glc ∆CO2/∆Glc normε  
-1.57 2.33 1.14 1.49 0.73 0.136 
-1.53 2.25 1.11 1.47 0.72 0.144 0 
-1.49 2.35 1.30 1.57 0.87 0.070 
-1.62 2.67 1.15 1.64 0.71 0.060 
-1.26 2.25 0.83 1.79 0.66 -0.005 6 
-1.66 2.58 0.76 1.55 0.46 0.149 
-1.14 1.88 0.97 1.65 0.85 0.035 
-1.19 2.09 0.52 1.76 0.43 0.049 9 
-1.29 2.08 0.64 1.61 0.49 0.113 
-0.94 1.18 0.75 1.25 0.79 0.241 
-1.21 1.56 0.74 1.28 0.61 0.256 15 
-1.06 1.36 0.76 1.28 0.72 0.241 
-0.78 0.68 0.48 0.87 0.61 0.465 
-0.92 0.91 0.55 1.00 0.60 0.401 30 
-0.77 0.70 0.55 0.91 0.71 0.429 
-0.67 0.53 0.42 0.79 0.63 0.499 
-0.84 0.48 0.54 0.57 0.65 0.606 50 
-0.78 0.59 0.55 0.76 0.71 0.501 
 
 
Fibroblast cells metabolism responded to four chemicals differently as indicated 
by changes in concentration differences of glucose, lactate, and CO2 (Figure 5.2). 
Monotonic decreases for all three metabolites were observed with increasing 
concentrations of oxamate. The differences from control were significant at 9 mM and 
greater. Similar responses of the three metabolites were observed with fluoride. The 
difference from control is significant at 1 and 3 mM. In contrast, antimycin A induced 
increased concentration differences of glucose and lactate while decreased concentration 
differences of CO2. Significant changes were observed at 2.5×10-6 mM and the impact 
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reached saturation at 1×10-5 mM. Contrary to the effect of oxamate and fluoride, DNP 
caused simultaneous increases for all three metabolites with increasing concentrations. 
Comparison of sensitivities of responses of the three metabolic rates to each chemical 
The extents to which the responses of the three metabolic rates (changes in 
concentration difference) to each given chemical were compared based on response 
coefficients (Figure 5.3). The response coefficient indicates the sensitivity of the response 
of one metabolic rate to the concentration changes of a given chemical, which is 
calculated as  
minmax
minmax
lnln
lnln
ln
ln
CC
MetMet
C
Met
−
∆−∆=∂
∆∂       (5-15)  
in which maxMet∆ and minMet∆ are observed maximum and minimum changes of 
concentration differences for a metabolite, and maxC and minC are corresponding tested 
concentration points. For oxamate, the response of lactate is most sensitive, whose 
response coefficient is about three times greater than those for glucose and CO2. For 
antimycin A, the CO2 response is most sensitive with a response coefficient about three 
times greater than those for glucose and lactate. For fluoride and DNP, no metabolite is 
significantly more sensitive than others at a 95% confidence level. 
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Figure 5.2. Changes in concentration differences of glucose, lactate, and CO2 of 
fibroblast cell cultures exposed for 6 h to different concentrations of oxamate (A), 
fluoride (B), antimycin A (C), and DNP (D). Black bars represent glucose, white bars 
represent lactate, and gray bars represent CO2. Measured points shown in the figure are 
averages and standard error of the mean of three replicates from a single 24-well plate. 
“∗” represents changes in metabolite concentrations significantly different from the 
control at a 95% confidence level. Each experiment was replicated twice (Only one 
replicate for each compound is shown). 
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Figure 5.3. Comparison of responses of metabolic rates of glucose, lactate, and CO2 to 
each chemical. Black, while, and gray bars represent the response coefficients of glucose, 
lactate, and CO2 respectively. Results in the figure are the average and standard error of 
the mean of 6 replicates measured from two separate 24-well plate experiments. 
 
 
 
Metabolic shift indicated by changes in ratios of metabolic rates  
The co-measurement of multiple metabolites allows metabolic rate to be 
analyzed. The data collected from each well yield ratios of lacC∆ / glcC∆ and 
2CO
C∆ / glcC∆ (Table 5.3). The averages of 6 replicates for each condition from two 
repeated well plate experiments were then calculated and plotted as a function of doses 
(Figure 5.4.). Oxamate caused significant, continuous decreases in ratios of 
lacC∆ / glcC∆ with increasing concentrations from 15 mM, while changes in 
2CO
C∆ / glcC∆ are not significant for all tested concentrations. Contrary to oxamate, 
antimycin A caused significant decreases in ratios of 
2CO
C∆ / glcC∆ at 2.5×10-6 mM and 
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greater, while ratios of lacC∆ / glcC∆ were constant at all concentrations. For fluoride and 
DNP, changes in lacC∆ / glcC∆  and 2COC∆ / glcC∆  were not observed at all concentrations 
tested. 
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Figure 5.4. Changes in ratios of concentration differences of metabolites of fibroblast 
cell cultures exposed to four chemicals. Black bars represent ratios of lacC∆ / glcC∆ , and 
white bars represent ratio of 
2CO
C∆ / glcC∆ . Each point shown in the figure is the average 
and standard error of the mean of 6 replicates measured from two separate 24-well plates, 
each plate with three replicates. “∗” represents that differences from the control are 
significant at a 95% confidence level. 
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Changes in consistency between the carbon balance and the measured metabolic rates  
The co-measurement of three metabolites allows further analysis of consistencies 
between the data sets and an assumed simple network. A normalized residual was 
calculated for every well (Table 5.3). Multiple replicates allow statistical analysis. The 
consistency was first checked for control cultures. The average of normalized residuals 
from 30 wells that served as control over 10 different experiments is 0.067, which is only 
slightly greater than 0.000, but the difference is significant at a 95% confidence level. 
Thus, the measured data sets for control cultures are not consistent with the assumed 
metabolic network. Moreover, more carbon is entering cells as glucose than can be 
accounted for by the carbon leaving as lactate and CO2. As expected, the 30 normalized 
residuals from control cultures follow a normal distribution (Figure 5.5), which confirms 
our ability to compare averages of residuals between different test conditions using t-
tests. 
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Figure 5.5. Frequency distributions of normε  calculated from 30 control cultures. “g” 
denotes the percentage of frequency of normalized residuals falling within the range 
interval. The Solid line is simulated using the normal distribution function, 
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Even though the data sets are not consistent with the network, changes in 
consistencies as functions of doses for a given chemical can be quantified and compared 
statistically (Figure 5-6). Oxamate caused increases in the normalized residuals in a 
monotonic manner up to 0.6 at 50 mM. Their differences from control were significant at 
15 mM and greater. Antimycin A also induced significant increases in normalized 
residuals at 1×10-5 mM and greater. The increases did not exceed 4.21. For cultures 
treated with fluoride or DNP, the differences from control are not consistent at all tested 
concentrations. 
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Figure 5.6. Normalized residuals for fibroblast cells exposed to four chemicals. Each 
point shown is the average and standard error of the mean of 6 normalized residuals for a 
given condition. “∗” represents changes in average normε  significantly different from the 
control at 95% C.D. 
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As summarized in figure 5-7, the metabolic state of fibroblast cells changed in 
three different ways in response to four chemicals at different levels: (1) changes in 
metabolic rates without changing relative ratios and consistencies, (2) metabolic shift 
indicated by changes in relative ratios of metabolic rates but without changing 
consistencies, and (3) metabolic switch indicated by changes in consistencies. One, two 
or three types of changes may be observed for a chemical at different doses. Changes in 
metabolic rates of the three metabolites induced by DNP and fluoride at all tested 
concentrations were proportional, compared to control, with ratios and consistencies 
remaining constant. For oxamate, changes in metabolic rates were observed at 9 mM 
without causing changes in ratios and consistencies, and changes in ratios and 
consistencies were observed at 15 mM and greater. For antimycin A, changes in 
metabolic rates and ratio were both observed at 2.5×10-6 mM and 5×10-6 mM, and all 
three types of changes were observed at 1×10-5 mM and greater. Based on the 
concentration range where the type of change is located, change in ratios is a subset of 
change in metabolic rates, and change in consistencies is a subset of change in ratios.  
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Figure 5.7. Changes in metabolic state of fibroblast cells exposed to four chemicals. 
White bars indicate the zone where no any effects occur, white bars with horizontal lines 
inside indicate the zone where rates change, white bars with vertical lines inside indicate 
the zone where pathway shift occurs, and grey bars indicate the zone where pathway 
switch occur. The mixed symbols means types of changes are overlapped. Doses of each 
chemical are normalized to their maximum tested sublethal concentration, oxamate at 50 
mM, fluoride at 3 mM, antimycin A at 1×10-4 mM, and DNP at 0.01 mM. 
 
 
Discussion  
In this work, a new 24-well plate assay was developed for measuring average 
metabolic rates (changes in concentrations) of glucose, lactate, and CO2 of mammalian 
cells. The rates were measured during a short, 6-hr incubation period so that changes in 
metabolite concentrations are sufficient to detect a difference, but not so much as to 
affect cell physiology and metabolic states. The metabolites were analyzed using 
enzymatic methods, which have been reformulated to a minimized scale and allows for 
multiplexed detection using spectrophotometric microplate readers. The assay in 
conjunction with a carbon balance based network provides a simple way for metabolic 
flux analysis with reduced cost, increased throughput, and reproducibility. It allows for 
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getting metabolic rates with adequate replication and doing consistency for adherent, 
non-growing cells that cannot be analyzed in a continuous culture. Achievement of rates 
with multiple replicates enhanced statistical analysis of the data sets and made 
consistency testing more rigorous. 
The new assay was first applied for charactering the abilities of chemicals to alter 
metabolic state of fibroblast cells. The four tested model chemicals are well known 
metabolic agents with well-characterized mechanisms of action and have often been used 
for metabolic studies. Oxamate acts on LDH to inhibit conversion of pyruvate to lactate. 
Inhibition of this reaction reduces NAD+ and causes a build up of glyceraldyhyde-3-
phosphate, which in turn raises the levels of fructose-1,6-bisphosphate and inhibits 
phosphofructokinase, thereby halting glycolysis.38 Inhibition of conversion of glucose to 
pyruvate, which is also the substrate for the TCA cycle, will decrease CO2 production. 
Fluoride inhibits glycolysis by blocking substrate binding to enolase, thereby both the 
aerobic and anaerobic reactions are decreased.27,39 Antimycin A blocks complex III in the 
electron transport chain and inhibits respiration.30,40 DNP uncouples electron transport 
from ATP synthesis and stimulate respiration.31,41-43 Both agents decrease the efficiency 
of energy production and the consequent increase in energy demand is contested by 
increasing glucose to produce ATP via glycolysis. Inhibition of glucose consumption and 
lactate production by oxamate and fluoride has been reported.26,44 Alternatively, 
stimulation of glucose consumption and lactate production by antimycin A and DNP has 
also been reported.26,42,43,45-47 The observed increased and decreased concentration 
differences of glucose, lactate, and CO2 witnessed in our results agreed with the 
mechanisms of action and results reported previous. 
 121
Further data analysis by ratios and consistency checking indicated three types of 
changes in metabolic states of fibroblast cells in response to four chemicals at different 
levels. In such a short 6 hr incubation period, the chance to regulate the metabolic 
pathway through the genetic mutation and the gene expression is very small. The 
regulation of the enzyme activity is the most possible reason. Relating the targeted 
enzyme to the response sensitivity of metabolites uncovered an interesting phenomenon: 
the most sensitive metabolite to a chemical is the closest one to the action site. If this is a 
general phenomenon, the method could be used to generate clues for pinpointing action 
sites of chemicals. 
Combination of the assay and certain cell lines could provide a way to 
characterize the chemicals with more detailed information. In turn, combination of the 
assay and chemicals with well-characterized effects may also provide a way to 
characterize cell lines. The action sites of the four agents tested are in or closely related to 
glycolysis, reduction of pyruvate to lactate, and TCA cycle, which are connected by a 
branch point of pyruvate. When one pathway was blocked, flux distribution into the other 
two pathways did not change as indicated by the constant relative ratios of metabolic 
rates as the function of doses. This suggests that pyruvate is a very rigid branch point, 
around which one flux perturbation will not have an appreciable effect on the distribution 
of the other two fluxes. 
Consistency testing indicated another interesting phenomenon. The network 
matched the data sets fairly well for control cultures. However, carbon balance was 
severely broken for antimycin A and oxamate at some levels as indicated by the 
normalized residuals. The maximum normalized residual is up to 0.58 at 50 mM of 
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oxamate, which suggests that 58% percent of carbon being produced by glucose did not 
end as lactate and CO2. It has been reported that a larger fraction of the carbon from 
glucose was directed to biomass at the low lacC∆ / glcC∆ .48 The lost carbon also could be 
ended as other extracellular metabolites (such as alanine), pile up in certain intracellular 
intermediate (s), or go to RNA and DNA through the pentose phosphate pathway, saved 
in glycogen, or synthesized to lipids. Answering where the lost carbon go needs second 
tier investigations of total cell mass analysis, lipid analysis, protein analysis, etc. 
Development of the method was intended for screening impacts of chemicals on 
cellular metabolism. The method allows parallel tests of chemicals at many doses. The 
information obtained is high content and mechanism indicative. Many improvements and 
extensions of this work are necessary, such as automation of the procedures, 
measurement of more metabolic parameters, and screening broader sets of chemicals. It 
should be beneficial as a complement to genomics and proteomics for more systemic 
information. Other applications of the method include functional characterization of 
metabolic state for drug action on desired target and other targets for pharmaceutical 
research, cell line selection, medium design, and optimization of additives for enhanced 
pharmaceutical production, identification of the suitable target for genetic modification in 
metabolic engineering.  
 
References 
 
1. Flint, O.P. (1998). Predicting in vivo toxicity. Toxicol Vitro 12, 591-595. 
 123
2. Zucco, F. and A.L. Vignoli. (1998). In vitro toxicology in Europe 1986-1997 - 
Final report to the European Commission DGXI Financial Contribution no. B4-
3040/96/424/DEB/E2. Toxicol Vitro 12, 739-+. 
3. Freshney, R.I. (2000). Introduction, pp. 4-5. In Culture of animal cells, a manual 
of basic techniques. A John Wiley & Sons, New York, USA. 
4. Waterfield, C.J., J. Delaney, M.D.J. Kerai and J.A. Timbrell. (1997). Correlations 
between in vivo and in vitro effects of toxic compounds: Studies with hydrazine. 
Toxicol Vitro 11, 217-227. 
5. Eisenbrand, G., B. Pool-Zobel, V. Baker, M. Balls, B.J. Blaauboer, A. Boobis, A. 
Carere, S. Kevekordes, J.C. Lhuguenot, R. Pieters and J. Kleiner. (2002). 
Methods of in vitro toxicology. Food Chem Toxicol 40, 193-236. 
6. Zucco, F., I. De Angelis, E. Testai and A. Stammati. (2004). Toxicology 
investigations with cell culture systems: 20 years after. Toxicol Vitro 18, 153-163. 
7. Orphanides, G. (2003). Toxicogenomics: challenges and opportunities. Toxicol 
Lett 140, 145-148. 
8. Lord, P.G. (2004). Progress in applying genomics in drug development. Toxicol 
Lett 149, 371-375. 
9. Hellmold, H., C.B. Nilsson, I. Schuppe-Koistinen, K. Kenne and L. Warngard. 
(2002). Identification of end points relevant to detection of potentially adverse 
drug reactions. Toxicol Lett 127, 239-243. 
10. Perlman, Z.E., M.D. Slack, Y. Feng, T.J. Mitchison, L.F. Wu and S.J. Altschuler. 
(2004). Multidimensional Drug Profiling By Automated Microscopy. Science 
306, 1194-1198. 
11. Nicholson, J.K., J. Connelly, J.C. Lindon and E. Holmes. (2002). Metabonomics: 
a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1, 
153-161. 
12. Lindon, J.C., J.K. Nicholson, E. Holmes and J.R. Everett. (2000). Metabonomics: 
Metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn 
Resonance 12, 289-320. 
13. Korke, R., A. Rink, T.K. Seow, M.C.M. Chung, C.W. Beattie and W.S. Hu. 
(2002). Genomic and proteomic perspectives in cell culture engineering. J 
Biotechnol 94, 73-92. 
14. Stephanopoulos G. (1999). Metabolic fluxes and metabolic engineering. Metab 
Eng 1, 1-11. 
 124
15. Balcarcel, R.R. and L.M. Clark. (2003). Metabolic screening of mammalian cell 
cultures using well- plates. Biotechnol Prog 19, 98-108. 
16. Lee, K., F. Berthiaume, G.N. Stephanopoulos and M.L. Yarmush. (1999). 
Metabolic flux analysis: A powerful tool for monitoring tissue function. Tissue 
Eng 5, 347-368. 
17. Shimizu, K. (2000). An overview on metabolic systems engineering approach and 
its future perspectives for efficient microbial fermentation. J Chin Inst Chem Eng 
31, 429-442. 
18. Fischer, E., N. Zamboni and U. Sauer. (2004). High-throughput metabolic flux 
analysis based on gas chromatography-mass spectrometry derived C-13 
constraints. Anal Biochem 325, 308-316. 
19. Sauer, U. (2004). High-throughput phenomics: experimental methods for 
mapping fluxomes. Current Opinion in Biotechnology 15, 58-63. 
20. Kumar, S., C. Wittmann and E. Heinzle. (2004). Minibioreactors. Biotechnology 
Letters 26, 1-10. 
21. John, G.T., I. Klimant, C. Wittmann and E. Heinzle. (2003). Integrated optical 
sensing of dissolved oxygen in microtiter plates: A novel tool for microbial 
cultivation. Biotechnol Bioeng 81, 829-836. 
22. Wodnicka, M., R.D. Guarino, J.J. Hemperly, M.R. Timmins, D. Stitt and J.B. 
Pitner. (2000). Novel fluorescent technology platform for high throughput 
cytotoxicity and proliferation assays. J Biomol Screen 5, 141-152. 
23. Yang, Y. and R.R. Balcarcel. (2003). 24-well plate spectrophotometric assay for 
preliminary screening of metabolic activity. Assay and drug development 
technologies 1, 461-468. 
24. Yang, Y.S. and R.R. Balcarcel. (2004). 96-Well Plate Assay for Sublethal 
Metabolic Activity. Assay and drug development technologies 2, 353-361. 
25. Yang, Y.S. and R.R. Balcarcel. (2004). Determination of carbon dioxide 
production rates for mammalian cells in 24-well plates. Biotechniques 36, 286-+. 
26. Eklund, S.E., D. Taylor, E. Kozlov, A. Prokop and D.E. Cliffel. (2004). A 
microphysiometer for simultaneous measurement of changes in extracellular 
glucose, lactate, oxygen, and acidification rate. Anal Chem 76, 519-527. 
27. Niknahad, H., S. Khan, C. Sood and P.J. Obrien. (1994). Prevention of Cyanide-
Induced Cytotoxicity by Nutrients in Isolated Rat Hepatocytes. Toxicol Appl 
Pharmacol 128, 271-279. 
 125
28. Kerai, M.D.J. and J.A. Timbrell. (1997). Effect of fructose on the biochemical 
toxicity of hydrazine in isolated rat hepatocytes. Toxicology 120, 221-230. 
29. Hamilton, E., M. Fennell and D.M. Stafford. (1995). Modification of Tumor 
Glucose-Metabolism for Therapeutic Benefit. Acta Oncologica 34, 429-433. 
30. Zhang, J.G., M.A. Tirmenstein, F.A. Nicholls-Grzemski and M.W. Fariss. (2001). 
Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent 
and -independent cell death: Protective role of antioxidants. Arch Biochem 
Biophys 393, 87-96. 
31. Linsinger, G., S. Wilhelm, H. Wagner and G. Hacker. (1999). Uncouplers of 
oxidative phosphorylation can enhance a Fas death signal. Mol Cell Biol 19, 
3299-3311. 
32. Yang, Y.S. and R.R. Balcarcel. (2003). 24-well plate spectrophotometric assay for 
preliminary screening of metabolic activity. Assay and Drug Development 
Technologies 1, 461-468. 
33. Forrester, R.L., L.J. Wataji, D.A. Silverman and K.J. Pierre. (1976). Enzymatic 
Method for Determination of CO2 in Serum. Clin Chem 22, 243-245. 
34. Bergmeyer, H.U. (1974). Methods of Enzymatic Analysis. Academic Press, New 
York, USA. 
35. Lowry, O.H. and J.V. Passonneau. (1972). A flexible System of Enzymatic 
Analysis;. Academic Press, Orlando, USA. 
36. Nyberg, G.B., R.R. Balcarcel, B.D. Follstad, G. Stephanopoulos and D.I.C. 
Wang. (1999). Metabolism of peptide amino acids by Chinese hamster ovary cells 
grown in a complex medium. Biotechnol Bioeng 62, 324-335. 
37. Stephanopoulos G., A.A.A., Nielsen Jens. (1998). Metabolic Engineering: 
Principles and Methodologies. 22. 
38. Goldberg, E.B. and S.P. Colowick. (1965). The role of glycolysis in the growth of 
tumor cells, III. Lactic dehydrogenase as the site of action of oxamate on the 
growth of cultured cells. J Biol Chem 240, 2786-2790. 
39. Voet, D., J.G. Voet and C.W. Pratt. (1999). Fundamentals of Biochemistry. John 
Wiley & Sons, New York. 
40. Gniadecki, R., T. Thorn and J. Vicanova. (2000). Role of Mitochondria in 
Ultraviolet-Induced Oxidative Stress. Journal of Cellular Biochemistry 80, 216-
222. 
41. Khayat, Z.A., T. Tsakiridis, A. Ueyama, R. Somwar, Y. Ebina and A. Klip. 
(1998). Rapid stimulation of glucose transport by mitochondrial uncoupling 
 126
depends in part on cytosolic Ca2+ and cPKC. American Journal of Physiology-
Cell Physiology 44, C1487-C1497. 
42. Sibille, B., C. Filippi, M.A. Piquet, P. Leclercq, E. Fontaine, X. Ronot, M. 
Rigoulet and X. Leverve. (2001). The mitochondrial consequences of uncoupling 
intact cells depend on the nature of the exogenous substrate. Biochem J 355, 231-
235. 
43. Sibille, B., X. Ronot, C. Filippi, V. Nogueira, C. Keriel and X. Leverve. (1998). 
2,4 dinitrophenol-uncoupling effect on Delta Psi in living hepatocytes depends on 
reducing-equivalent supply. Cytometry 32, 102-108. 
44. Sanfeliu, A., C. Paredes, J.J. Cairo and F. Godia. (1997). Identification of key 
patterns in the metabolism of hybridoma cells in culture. Enzyme Microb Technol 
21, 421-428. 
45. Tiefenthaler, M., A. Amberger, N. Bacher, B.L. Hartmann, R. Margreiter, R. 
Kofler and G. Konwalinka. (2001). Increased lactate production follows loss of 
mitochondrial membrane potential during apoptosis of human leukaemia cells. Br 
J Haematol 114, 574-580. 
46. Pilatus, U., E. Aboagye, D. Artemov, N. Mori, E. Ackerstaff and Z.M. Bhujwalla. 
(2001). Real-time measurements of cellular oxygen consumption, pH, and energy 
metabolism using nuclear magnetic resonance spectroscopy. Magnetic Resonance 
in Medicine 45, 749-755. 
47. Patel, N., Z.A. Khayat, N.B. Ruderman and A. Klip. (2001). Dissociation of 5' 
AMP-activated Protein Kinase Activation and Glucose Uptake Stimulation by 
Mitochondrial Uncoupling and Hyperosmolar Stress: Differential Sensitivities to 
Intracellular Ca2+ and Protein Kinase C Inhibition. Biochem Biophys Res Commun 
285, 1066-1070. 
48. Gambhir, A.K., R.; Lee, J.; Fu, P. C.; Europa, A. F.; Hu, W. S. (2003). Analysis 
of Cellular Metabolism of Hybridoma Cells at Distinct Physiological States. J 
Biosci Bioeng 95, 317-327. 
 
  
 
 127
CHAPTER VI 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
Conclusions 
The overall aim described in the introduction of this thesis was to develop high 
throughput metabolic rate assays for screening purposes. At the start of my work, 
established approaches for measuring metabolic rates were primarily for large-scale 
cultivation systems. Such methods are expensive, time consuming, low throughput, all 
which are obstacles for applications of metabolic flux analysis method in areas that 
require large numbers of test, such as screening of drugs and toxicants in drug discovery 
and development and screening of mutants in functional genomics. Now at the end of my 
work, a series of metabolic rate assays performed in 24- and 96-well plates are developed 
and demonstrated for use in screening chemicals (Table 6.1).1-3 The assays were 
demonstrated to be more sensitive for toxicity testing than those based on cell death 
events, and have comparable sensitivity with cell growth inhibition. A sublethal screen 
provides a simple solution to overcome the challenge of dose selection faced by users of 
many intricate approaches. Measurement of multiple metabolic rates in well plates 
enables characterization of compounds for their abilities to alter metabolic state as a 
function of doses and the information obtained is mechanism indicative.  
The assays developed in this work help strengthen the field of metabolic flux 
analysis by providing an easy way to obtain sets of fluxes with adequate replicates. 
Achievement of fluxes with multiple replicates, collected from multi-parallel cultures in 
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well plates, resulted in the ability to not only increase the precision of the fluxes 
measured but also enhance the statistical analysis of data sets for more rigorous 
consistency testing. The statistical analysis of central carbon balance enabled quantitative 
comparison of deviations of flux data sets from a network at different metabolic states, 
though inability of closing the carbon balance by measuring glucose, lactate, and CO2 
suggested that more metabolic parameter be measured.  
 
Table 6.1. Summary of metabolic rate assays developed in this work. 
Assay Name Well plate Time Application 
Acidification rate 24 90 minutes 
Rapid screening for a preliminary 
dose response curve of effects on 
global metabolism  
CO2 production 24 6 hours 
Screening for a dose response curve 
of effects on respiration 
Sublethal activity 96 6 and 24 hours 
Screening for two dose response 
curves of effects on metabolism and 
viability to determine sub-lethal 
concentration range 
Glc/Lac/CO2 24 6 hours 
Screening for effects on several 
pathways to characterize changes in 
metabolic state 
 
 
Recommendations 
The assays were designed to meet different purposes. To test a chemical, they can 
be used in a sequence; the easier ones should be used first to pave the way for the use of 
relatively complicated ones, which can increase the overall efficiency and reduce the total 
cost of a testing process. They also can be used in parallel with other assays in a complex 
testing strategy. Certainly, many improvements and extensions of my work are necessary. 
These include but are not limited to adapting of the assays for automation, measurement 
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of more metabolic rates, validation for toxicity prediction, and extension to wider 
research areas. 
(1) Improvements 
 Currently, all procedures of the assays that I have developed, such as cell 
seeding, culture incubation, and metabolite assays, were operated manually in 24- and 
96-well plates. Automation of the assay requires further improvements with respect to 
procedures and assay reagents. In my work, cell seeding is the most tedious step, which 
might be overcome by using automatic liquid handling systems. The protocols should be 
further simplified and avoid those which are not suitable for automatic operations, such 
as washing steps. Minimization is the trend for high throughput screening. The enzymatic 
assays for metabolite measurements should be further minimized and optimized. Higher 
densities well plates, such as 384-well plates, are necessary to further increase the 
throughput. Moreover, more metabolites, such as amino acids, should be measured and 
added into current systems for a more detailed metabolic map. Methods that allow 
multiplexed detections, such as those light-based, are preferred for metabolite 
measurements. Other techniques, such as HPLC, GC, NMR, and Mass spectroscopy also 
can be considered.   
(2) Test broader chemicals and cell lines 
 My work has demonstrated the feasibility of measuring metabolic rates in 
high throughput well plates using a regular, continuous cell line (mouse fibroblast) and a 
few well-known metabolic agents. Their uses for toxicity prediction have not been 
validated yet. Broader species/cell types and chemical reference sets should be tested. 
Genomics and proteomics have been tested for toxicity prediction purposes with some 
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biological system models and chemicals. Testing same biological systems and chemicals 
for metabolic effects and relating the results to those measured by genomics and 
proteomics as well as to results measured by classical toxicity endpoints would be a good 
starting point.  
(3) Biopharmaceutical process development 
Optimization of culture environment and development of highly productive cell 
lines are important for the design of high-yield processes in biopharmaceutical process 
development. The process of medium optimization is a slow, grueling, and tedious 
process due to a large number of components contained in the medium and their 
complicated interactions. The components of current medium used for industrial cell lines 
are far being fully optimized and require much further improvements. Increasing specific 
productivity of monoclonal antibody production, maximization of cell density, elongation 
of culture period, and minimization of toxic byproducts (such as lactate and ammonia), 
are major aims for optimization of medium.4,5 The well plate-based metabolic rate assays 
that I have developed provide measurements of several endpoints concerned by medium 
optimization, including cell growth, glucose consumption, and lactate production. When 
they are complemented with more necessary endpoints, such as monoclonal antibody and 
ammonia production, a powerful platform will be created for medium optimization 
process. Moreover, the assay can be used for screening and identification of new 
chemical enhancers as medium additives. 
Another possible application of well plate-based metabolic rate assays is to 
investigate cellular metabolism and signaling pathways that influence proliferation and 
productivity. Activation of membrane-bound receptor and signal transduction pathways 
 131
will alter cellular metabolic state. By employing cell signaling and metabolic inhibitors 
and modulators and the metabolic rate assays, much information can be revealed 
regarding the nature of signal transduction and metabolic pathways. Achievement of 
relation between these pathways and cell physiology will open new areas for further 
improvement of cellular properties.  
(4) Measure flux control coefficients 
 Metabolic control analysis (MCA) provides a methodology to describe 
how cells regulate metabolism in response to changes in system parameters of complex 
enzyme systems.6 In MCA, the control exerted by each enzyme in a metabolic network 
over metabolic fluxes is described quantitatively as a control coefficient. Determination 
of control coefficients of enzymes in pathways can help identify the target for genetic 
modifications in metabolic engineering and for disease treatment in drug discovery and 
pharmaceutical research.7 The flux control coefficient is defined as the fractional change 
in the logarithm of flux against the fractional change in logarithm of enzyme activity.  
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where I  represents inhibitor, JIR  represents response coefficient (defined as 
fractional changes in fluxes over fractional changes in concentrations of the inhibitor), 
and xaseIε  represents elasticity (defined as fractional changes in enzyme activity over 
fractional changes in concentrations of the inhibitor). My work has demonstrated the 
feasibility for determining response coefficients in well plates in chapter V. The 
measurement of enzyme activity has previously often been performed in well plates. 
Thus, in the future, they may be combined and further optimized, yielding an easy, 
inexpensive method for determination of flux coefficients.    
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